All articles tagged: Pharmacy
HealthDay
20 November at 11.06 AM
Four Million Americans Could Lose Health Coverage Once ACA Credits ExpireIf Congress lets health care tax credits established during the pandemic expire, 4 million Americans will become uninsured, a new analysis warns.The tax credits, which have significantly lowered out-of-pocket costs for millions of Americans, are set to expire at the end of 2025."Allowing these credits to expire will force families to c |
HealthDay
19 November at 11.50 PM
President-Elect Trump to Pick Mehmet Oz to Head CMSPresident-elect Donald Trump says he will nominate Mehmet Oz, M.D., to head the Centers for Medicare & Medicaid Services.In a statement, Trump said that Oz will "work closely with Robert Kennedy Jr. to take on the illness industrial complex, and all the horrible chronic diseases left in its wake," The New York Times reported. Trump |
HealthDay
19 November at 11.47 PM
Antiviral Treatment Underutilized for Children, Teens With FluAntiviral treatment is underutilized among children and adolescents hospitalized with influenza, according to research published in the Nov. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Using data from two U.S. influenza surveillance networks, Aaron M. Frutos, Ph.D., from the CDC |
HealthDay
19 November at 04.34 PM
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD StageFor patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage, according to a study published online Nov. 19 in the Annals of Internal Medicine.Steven T. Bird, Ph.D., Pharm.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and coll |
HealthDay
19 November at 04.28 PM
ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related DiseaseFor patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the likelihood of flare-free complete remission, according to a study published online Nov. 14 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 14 t |
HealthDay
19 November at 04.22 PM
ACR: Colchicine No Benefit for Painful Knee OsteoarthritisColchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 14 to 19 in Washington, D.C.Jonathan Samuels, M.D., from NYU Langone in Rye Brook, New York, and colleagues assessed wh |
HealthDay
19 November at 03.53 PM
Barriers to Widespread Access to Cancer Medications Include Excessive CostBarriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review published online Nov. 18 in Cancer.Arafat H. Tfayli, M.D., from the American University of Beirut Medical Center, and colleagues conducted a systematic review to examine the current state of cancer drug development |
HealthDay
19 November at 01.29 PM
Judge Declares Wyoming's Abortion Bans UnconstitutionalTwo Wyoming abortion bans, including the first state law to prohibit the use of abortion pills, violate the state's constitution, a judge ruled Monday.In her decision, Judge Melissa Owens, of Teton County District Court, wrote that both a <a href="https://wyoleg.gov/Legislation/2023/SF0109" |
HealthDay
18 November at 10.56 PM
Global Coverage With Measles Vaccine Declined During COVID-19Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023, according to research published in the Nov. 14 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Anna A. Minta, M.D., from the Worl |
HealthDay
18 November at 10.38 PM
Metformin Use Tied to Lower Rate of Asthma AttacksMetformin is associated with a lower rate of asthma attacks among people with diabetes, according to a study published online Nov. 18 in JAMA Internal Medicine.Bohee Lee, Ph.D., from Imperial College London, and colleagues estimated the association of metformin and add-on antidiabetic medications (glucagon-like peptide-1 receptor a |
HealthDay
18 November at 10.35 PM
Gabapentinoid Use Tied to Higher Risk for Hip FracturesGabapentinoid use is associated with an increased risk for hip fractures, according to a study published online Nov. 13 in JAMA Network Open.Miriam T.Y. Leung, from the Centre for Medicine Use and Safety at Monash University in Melbourne, Australia, and colleagues investigated the association between gabapentinoids and the risk for |
HealthDay
18 November at 04.48 PM
Oral Infigratinib Seems Safe for Children With AchondroplasiaFor children with achondroplasia, oral infigratinib does not result in major safety signals and yields increased annualized height velocity and z score at a dose of 125 mg, according to a study published online Nov. 18 in the New England Journal of Medicine.Ravi Savarirayan, M.B., B.S., M.D., from Murdoch Children's Research Institute i |
HealthDay
18 November at 04.34 PM
Beta Blockers May Cause Depressive SymptomsBeta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ejection fraction (LVEF), according to a study published online Oct. 3 in the European Heart Journal: Acute CardioVascular Care.Philip Leissner, from Uppsala University in Sweden, and |
HealthDay
18 November at 04.28 PM
ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal CancerFor patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising, according to a study published online Nov. 15 in Clinical Cancer Research.Xin Wang, from the Chinese Academy of Medical Sciences and Peking Union Medical C |
HealthDay
18 November at 04.21 PM
Tirzepatide Yields Sustained Weight Reduction in Obesity, PrediabetesFor patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published online Nov. 13 in the New England Journal of Medicine.Ania M. Jastreboff, M.D., Ph.D., from the Yale School of Medicine in New Haven |
HealthDay
18 November at 04.17 PM
Bleeding Risk Increased With NSAID Use for VTE Patients Receiving AnticoagulantsPatients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when using nonsteroidal anti-inflammatory drugs (NSAIDs), according to a study published online Nov. 17 in the European Heart Journal.Søren Riis Petersen, from Aarhus University Hospital in Denmark, and colleagues conducted a na |
HealthDay
14 November at 11.50 PM
FDA Approves Cobenfy for Adults With SchizophreniaThe U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.The oral medication represents the first new class of medicine in several decades and selectively targets M1 and M4 receptors in the bra |
HealthDay
14 November at 11.47 PM
President-Elect Trump Nominates Robert F. Kennedy Jr. to Lead HHSPresident-elect Donald Trump has chosen Robert F. Kennedy Jr. to head the U.S. Department of Health and Human Services.The department encompasses numerous key agencies, including the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, the National Institutes of Health, Medicaid, and Medicare.In a stat |
HealthDay
13 November at 01.10 PM
Big Post-Election Surge Seen in Online Sales of Morning-After PillsIn the wake of Donald Trump's victory in the presidential election, retailers report that online sales of emergency contraceptives have soared.The spike in purchases of what is also known as the morning-after pill or Plan B suggests women worry the incoming administration might soon limit their access to emergency contraception, <a href="http |
HealthDay
12 November at 09.32 PM
FDA Approves Emrosi for Rosacea in AdultsThe U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.The extended-release capsules (40 mg) will be available late in the first quarter or early in the second quarter of 2025.The approval was based on positive results from two 16-week phase 3 clinical tri |
HealthDay
12 November at 04.28 PM
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke SurvivorsFor patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced mortality, myocardial infarction (MI), and recurrent stroke, according to a study presented at the American Heart Association Scientific Sessions 2024, held from Nov. 16 to 18 in |
HealthDay
12 November at 03.56 PM
SGLT-2 Inhibitors Beneficial for Patients With NephrolithiasisFor patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence, according to a study published online Oct. 30 in The BMJ.Natalie McCormick, Ph.D., from Massachusetts General Hospital in Boston, and colleagues emulated target trials comparing recurrence of nephrolith |
HealthDay
08 November at 04.39 PM
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu ShotsReactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, according to a study published online Nov. 6 in JAMA Network Open.Emmanuel B. Walter, M.D., M.P.H., from the Duke University School of Medicine in Durham, North Carolina, and colleagues compared the reactogenicity, safety, |
HealthDay
07 November at 04.26 PM
FDA Proposes Ban on a 'Useless' Decongestant, PhenylephrineMore than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.Products that in |
HealthDay
07 November at 04.22 PM
Expanding Access to Obesity Medications Could Avert 42,000 Deaths/YearExpanding access to obesity medications such as glucagon-like peptide 1 (GLP-1) receptor agonists and dual gastric inhibitory polypeptide and GLP-1 receptor agonists could avert 42,000 deaths annually in the United States, according to a study published online Oct. 15 in the Proceedings of the National Academy of Sciences.Abhishek Pand |
HealthDay
07 November at 12.24 PM
Novo Nordisk CEO Warns of Deaths Linked to Compounded SemaglutideThe head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths.“Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO <a href="https://w |
HealthDay
06 November at 10.17 PM
Medication Abortion Before Confirmed Intrauterine Pregnancy NoninferiorFor complete abortion, medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment, according to a study published in the Nov. 7 issue of the New England Journal of Medicine.Karin Brandell, M.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a multicenter, noninferi |
HealthDay
06 November at 12.48 PM
Abortion Rights Measures Pass in 7 States, Fail in 3In election results that showed protecting women's reproductive freedoms matter to a majority of Americans, abortion rights measures passed in seven states and failed in three.Missouri, Arizona, Nevada, Colorado, New York, Maryland and Montana all backed those rights, while such amendments were defeated in Florida, Nebraska and South Dakota, l |
HealthDay
05 November at 04.34 PM
Smoking Cessation Aids Survival Even Following a Cancer DiagnosisEvidence-based smoking cessation treatment within six months of a cancer diagnosis maximizes survival benefit, according to a study published online Oct. 31 in JAMA Oncology.Paul M. Cinciripini, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the association between time of entry in |
HealthDay
05 November at 04.29 PM
Guidance Issued for Safe Use of GLP-1 RAs in the Perioperative PeriodIn a multisociety clinical practice guidance document, published online Oct. 29 in Surgery for Obesity and Related Diseases, recommendations are presented for the safe use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the perioperative period.Noting that GLP-1 RAs have revolutionized the care of patients with metabolic dis |
HealthDay
05 November at 04.19 PM
Recreational Cannabis Legalization Tied to Higher Prenatal UseThe implementation of recreational cannabis legalization (RCL) in California was associated with an increase in prenatal cannabis use, according to a study published online Nov. 1 in JAMA Health Forum.Kelly C. Young-Wolff, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues assessed whether RCL in Califo |
HealthDay
05 November at 11.04 AM
Medicaid Covers GLP-1 Meds for Obesity in Just 13 StatesLow-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.Under the Medicaid system, individual states are allowed to deci |
HealthDay
04 November at 04.32 PM
Multiple Penicillin Courses Linked to Modestly Lower Risk for Parkinson DiseaseAdults who have received multiple penicillin courses have a modestly lower risk for Parkinson disease (PD), according to a study published in the October issue of Parkinsonism and Related Disorders.Gian Pal, M.D., from the Rutgers-Robert Wood Johnson Medical School in New Brunswick, New Jersey, and colleagues conducted a nested case-cont |
HealthDay
04 November at 01.01 PM
In a National First, an Idaho Health Department Is Refusing to Give COVID VaccinesIn what may be a first for the United States, a regional public health department in Idaho will no longer provide COVID-19 vaccines, following a close vote by its board.“I’m not aware of anything else like this,” said Adriane Casalotti, chief of government and public affairs for the Nati |
HealthDay
01 November at 10.57 PM
Supply Chain Issues Less Likely to Yield Drug Shortages in Canada Versus U.S.Drug-related reports of supply chain issues are less likely to result in drug shortages in Canada than in the United States, according to a study published online Oct. 31 in the Journal of the American Medical Association.Mina Tadrous, Pharm.D., Ph.D., from the University of Toronto, and colleagues compared how frequently reports of drug |
HealthDay
01 November at 04.24 PM
Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet RecoveredCountries with COVID-19 pandemic-associated reductions in childhood immunization coverage have not yet recovered, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Camille E. Jones, Ph.D., from the CDC in Atlanta, and colleagues present trends |
HealthDay
01 November at 04.22 PM
Flu Vaccine Coverage 80.7 Percent for Health Workers in Acute Care HospitalsInfluenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7 and 15.3 percent, respectively, among health care personnel at acute care hospitals and is lower among health care personnel at nursing homes, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Repo |
HealthDay
01 November at 03.46 PM
Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DMFor patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications, according to a study published online Oct. 24 in Alzheimer's & Dementia.William Wang, from the Case Western Reserve University School of Medicine in |
HealthDay
01 November at 03.41 PM
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal CancerGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Temitope Olasehinde, M.D., from |
HealthDay
31 October at 03.38 PM
Semaglutide Beneficial for People With Obesity, Knee OsteoarthritisFor individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and pain related to knee osteoarthritis than placebo, according to a study published in the Oct. 31 issue of the New England Journal of Medicine.Henning Bliddal, M.D., from the Copenhagen University Hospital at Bispeb |
HealthDay
31 October at 03.35 PM
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast CancerInavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer, according to a study published in the Oct. 3 |
HealthDay
31 October at 03.22 PM
Micronized Amnion/Chorion Aids Interstitial Cystitis/Bladder Pain SyndromeInjected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with refractory interstitial cystitis/bladder pain syndrome (IC/BPS), according to a study published online Oct. 23 in International Urology & Nephrology.Kyle O’Hollaren, from Wayne State University School of Medic |
HealthDay
31 October at 03.05 PM
ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel SyndromeHormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Jacqueline Khalil, D.O., from Case Western Reserve University in |
HealthDay
30 October at 10.12 PM
Generic Medications Can Keep OOP Costs Down for Neurological ConditionsGeneric medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a study published online Oct. 30 in Neurology.Amanda V. Gusovsky, Ph.D., M.P.H., from the Wexner Medical Center at The Ohio State University in Columbus, and co |
HealthDay
30 October at 03.37 PM
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast CancerFor patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in The BMJ.Min He, from Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer, and colleagues conducted a randomized phase 3 trial in seven cancer centers |
HealthDay
30 October at 03.33 PM
Small but Important Differences Seen Between Rosuvastatin, AtorvastatinThere are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine.Shiyu Zhou, M.D., from Southern Medical University in Guangzhou, China, and colleagues compared the real-world effectiveness and |
HealthDay
30 October at 03.31 PM
ASN: Atrasentan Significantly and Clinically Meaningfully Cuts ProteinuriaAtrasentan is associated with a significant and clinically meaningful reduction in proteinuria compared with placebo in patients with immunoglobulin A (IgA) nephropathy, according to a study published online Oct. 25 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, |
HealthDay
29 October at 03.50 PM
Urine Drug Test Concentrations Up for Fentanyl, Methamphetamine, CocaineAbsolute concentrations of fentanyl, methamphetamine, and cocaine in urine specimens increased from 2013 to 2023, according to a study published online Oct. 24 in JAMA Network Open.Andrew S. Huhn, Ph.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues analyzed urine drug testing (UDT) results to q |
HealthDay
29 October at 03.48 PM
Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in SurgeriesAmong privately insured patients, there was a doubling in the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as antiobesity treatment from 2022 to 2023, with a simultaneous 25.6 percent decrease in the rate of metabolic bariatric surgery, according to a research letter published online Oct. 25 in JAMA Network Open.Ke |
HealthDay
29 October at 03.45 PM
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for AsthmaFor patients with asthma, inhaled corticosteroids (ICS) combined with short-acting β agonists (SABA) and ICS combined with the long-acting β agonist formoterol are each associated with reduced asthma exacerbations compared with SABA alone, according to a study published online Oct. 28 in the Journal of the American Medical Association. The st |
HealthDay
29 October at 03.42 PM
Clinical Practice Guideline Updated for Migraine, Tension-Type HeadacheIn a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of Internal Medicine, updated recommendations are presented for the management of migraine and tension-type headache (TTH).Noting that the 2020 U.S. Department of Veterans Af |
HealthDay
28 October at 10.38 PM
Clinical Practice Guidelines Updated for Primary Prevention of StrokeIn a clinical guideline issued by the American Heart Association and American Stroke Association and published online Oct. 21 in Stroke, updated recommendations are presented for the primary prevention of stroke.Cheryl Bushnell, M.D., from Wake Forest University in Winston-Salem, North Carolina, and colleagues conducted a systematic rev |
HealthDay
28 October at 04.06 PM
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With RifaximinFor patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the American College of Gastroenterology, held from Oct. 25 to 30 in Philadelphia.Jasmohan S. Bajaj, M.D., from Virginia Commonw |
HealthDay
28 October at 04.04 PM
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD PatientsEmpagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic kidney disease at risk for progression, according to a study published online Oct. 25 in the New England Journal of Medicine to coincide with Kidney Week, the annual meeting of the American Society of Nephrology, held fro |
HealthDay
28 October at 03.39 PM
2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1 DiabetesFrom 2010 to 2023, there was an increase in prescribing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and sodium glucose cotransporter 2 (SGLT2) inhibitors among individuals with type 1 diabetes (T1D), according to a research letter published online Oct. 23 in the Journal of the American Medical Association.Piaopiao Li, from |
HealthDay
25 October at 08.32 PM
Long-Term Upadacitinib Use Feasible for Adolescents With Atopic DermatitisLong-term treatment of adolescents with moderate-to-severe atopic dermatitis (AD) with upadacitinib is safe and effective through 76 weeks, according to a study published online Oct. 23 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues evaluated the effi |
HealthDay
25 October at 04.08 PM
ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe AllergyDelabeling patients with syphilis who believe they are allergic to penicillin is safe, according to a study presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.Aiwei Yan, M.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, and colleagues retrospec |
HealthDay
25 October at 04.05 PM
Cognitive Therapy, Modafinil, Combo All Beneficial for Multiple Sclerosis FatigueCognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue, according to a study published in the November issue of The Lancet Neurology. Tiffany J. Braley, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a randomized, comparative effectiveness |
HealthDay
25 October at 04.02 PM
ACAAI: Many Anaphylaxis Protocols Are Incomplete, OutdatedMany anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.Carly Gunderson, D.O., from the Baylor College of Medicine |
HealthDay
25 October at 03.56 PM
GIP/GLP-1 RA Beneficial for Patients With Opioid, Alcohol Use DisorderFor patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RA) are associated with lower rates of opioid overdose and alcohol intoxication, according to a study published online Oct. 16 in Addiction.< |
HealthDay
25 October at 11.58 AM
CDC Says Some People May Need Extra Dose of COVID VaccineSome Americans should get more than one shot of the updated COVID vaccines because their age or certain health conditions make them more vulnerable to severe infections, U.S. health officials advised this week.Six months after their first shot, people 65 and older and those who are immunocompromised should receive a second dose of the vacci |
HealthDay
24 October at 03.44 PM
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary AngioedemaFor adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, which is based on clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9, administered as a single dose reduces angioedema attacks, according to a study published online Oct. 24 in the New England Journal of Medicine to |
HealthDay
24 October at 12.30 PM
CDC Lowers Age for First Pneumococcal Vaccine to 50The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday."Lowering the age for pneumococcal vaccination gives more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infecti |
HealthDay
23 October at 03.47 PM
AAO: One Year of Valacyclovir Beneficial for Herpes Zoster OphthalmicusOne year of valacyclovir is beneficial for patients with herpes zoster ophthalmicus (HZO), according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Elisabeth Cohen, M.D., from the NYU Grossman School of Medicine and NYU Langone Health in New York City, and colleagues con |
HealthDay
23 October at 02.40 PM
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction CancerThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma who |
HealthDay
23 October at 12.40 PM
Abortions Have Increased, Even in States With Bans, Report FindsA new report shows the number of women getting abortions in the United States has actually increased since the U.S. Supreme Court overturned Roe v. Wade.Since March 2023, the #WeCount report found a small, consistent increase in abortion rates. |
HealthDay
22 October at 10.48 PM
AAO: Corneal Toxicity Reported With Mirvetuximab SoravtansineFor patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Filippos Vingopoulos, M.D., Ph.D., from Stanford Univers |
HealthDay
22 October at 10.47 PM
AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic ClinicsArtificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication, plastic, and cost, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held from Oct. 18 to 21 in Chicago.Noting that eye drops in ophthalmology clinics have artificial expiration dates |
HealthDay
22 October at 10.45 PM
FDA Approves Vyalev for Advanced Parkinson DiseaseThe U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson disease (PD).Vyalev is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced PD and allows for personalized dosing throughout the d |
HealthDay
22 October at 03.33 PM
No Objective Improvement Seen in Cognitive Function With Exercise During ChemoAerobic exercise does not result in differences in objective cognitive function after chemotherapy completion among women with breast cancer, according to a study published online Oct. 21 in Cancer.Jennifer Brunet, Ph.D., from the University of Ottawa in Ontario, Canada, and colleagues examined the effects of an aerobic exercise interv |
HealthDay
21 October at 10.49 PM
People With Inflammatory Bowel Disease Face Barriers to Health CarePatients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles, according to a study published online Oct. 8 in Inflammatory Bowel Diseases.Ariel A. Jordan, M.D., from University of Michigan in Ann Arbor, and colleagues surveyed IBD patients and their careg |
HealthDay
21 October at 03.50 PM
IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream InfectionsTreating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 days, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.Nick Daneman, M.D., and Rob Fowler, M.D., from the University |
HealthDay
21 October at 03.38 PM
Preexposure Prophylaxis Use Increased in Recent YearsPreexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 in the Journal of the American Medical Association.Laura M. Mann, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used the IQVIA Real-World Longitudinal Presc |
HealthDay
21 October at 03.35 PM
Pembrolizumab Aids Survival With High-Risk Endometrial CancerPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in the Journal of Clinical Oncology.Brian M. Slomovitz, M.D., from Mount Sinai Medical Center in Miami Beach, and colleagues conducted a |
HealthDay
21 October at 12.45 PM
Biden Proposes That Insurers Cover Over-the-Counter Birth ControlHealth insurers would be required to cover the cost of over-the-counter birth control and emergency contraception under new rules proposed by the White House on Monday."Since Roe v. Wade was overturned more than two years ago, Republican elected officials have made clear they want to ban or restrict birth control, defund federal programs that he |
HealthDay
18 October at 04.07 PM
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black RaceVaccination for influenza, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and respiratory syncytial virus (RSV) is less likely with an increasing social vulnerability index (SVI) and Black race, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Ange |
HealthDay
18 October at 03.35 PM
Annual Wasteful Spending on Lecanemab Estimated at $133 to $336 MillionAnnual wasteful spending on discarded lecanemab is anticipated to range between $133 and $336 million, given current vial sizes, according to a research letter published online Oct. 14 in JAMA Internal Medicine.Noting that lecanemab dosing is weight-based and only available in 500- and 200-mg vials, Frank F. Zhou, from the David Geffen |
HealthDay
17 October at 09.43 PM
IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for TeensThe Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.Catherine Mary Healy |
HealthDay
17 October at 09.40 PM
IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOMImplementation of an electronic health record (EHR) order set increases compliance with the recommended duration of prescribed antibiotics for children with acute otitis media (AOM), according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 16 to 19 in Los Angeles.Joana Dimo, D. |
HealthDay
17 October at 04.03 PM
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AISFrom 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Stroke.Victor Lomachinsky Torres, M.D., from Massachusetts General Hospital in Boston, and colleagues analyzed a 20 percent sample of U.S. Medicare claims from April 1, 2013, to Sep |
HealthDay
17 October at 03.59 PM
Tenecteplase Has Similar Safety to TPA for Acute Ischemic StrokeFor patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published online Oct. 16 in Neurology.Lina Palaiodimou, M.D., Ph.D., from the National and Kapodistrian University of Athens |
HealthDay
17 October at 03.39 PM
Paternal Metformin Use Does Not Increase Risk for Congenital MalformationsPaternal metformin use during the period of sperm development is not associated with an increased risk for congenital malformations in offspring, according to a study published online Oct. 16 in The BMJ.Lin-Chieh Meng, from the National Taiwan University, and colleagues examined the association between paternal metformin use and the r |
HealthDay
16 October at 09.55 PM
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin LymphomaFor patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD) yields longer progression-free survival (PFS) than brentuximab vedotin with doxorubicin, vinblastine, and dacarbazine (BV+AVD), according to a study published online Oct. 16 in the New England Journal of Medicine.Alex |
HealthDay
16 October at 03.25 PM
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAsPatients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin prescription, according to a research letter published online Oct. 16 in JAMA Network Open.Margaret G. Miller, from Case Western Re |
HealthDay
16 October at 03.19 PM
Risk for Most Cardiovascular Events Reduced After COVID-19 VaccinationCOVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis after mRNA vaccination, according to a study published online Sept. 30 in the European Heart Journal.Yiyi Xu, Ph.D., from the |
HealthDay
16 October at 03.06 PM
FDA Approves Itovebi for Locally Advanced, Metastatic Breast CancerThe U.S. Food and Drug Administration approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer.Th |
HealthDay
16 October at 03.02 PM
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEFFor individuals with heart failure with reduced ejection fraction (HFrEF), substantial mortality benefits would result from optimal use of guideline-directed medical therapy (GDMT), according to a study published online Oct. 2 in JAMA Cardiology.Amber B. Tang, M.D., from the University of California Los Angeles, and colleagues examin |
HealthDay
16 October at 02.51 PM
Rate of Layperson-Administered Naloxone Increased From 2020 to 2022The rate of layperson-administered naloxone (LAN) increased from 2020 to 2022, according to a study published online Oct. 14 in JAMA Network Open.Christopher B. Gage, from Ohio State University in Columbus, and colleagues assessed whether the frequency of LAN in conjunction with emergency medical services (EMS) activations chang |
HealthDay
15 October at 04.10 PM
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With ObesityFor adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct. 14 in JAMA Pediatrics.Liya Kerem, M.D., and Joshua Stokar, M.D., from Hadassah University Medical Center in Israel, examined the incid |
HealthDay
15 October at 04.10 PM
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With ObesityFor adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct. 14 in JAMA Pediatrics.Liya Kerem, M.D., and Joshua Stokar, M.D., from Hadassah University Medical Center in Israel, examined the incid |
HealthDay
15 October at 04.05 PM
American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid ShortageThe American Thoracic Society is providing tips to help hospitals mitigate impacts on intravenous (IV) fluid supply resulting from manufacturing disruptions due to recent hurricanes.W. Graham Carlos, M.D., and colleagues provide guidance on how health care systems facing shortages of these fluids may conserve fluids and address the shortages.</ |
HealthDay
15 October at 04.05 PM
American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid ShortageThe American Thoracic Society is providing tips to help hospitals mitigate impacts on intravenous (IV) fluid supply resulting from manufacturing disruptions due to recent hurricanes.W. Graham Carlos, M.D., and colleagues provide guidance on how health care systems facing shortages of these fluids may conserve fluids and address the shortages.</ |
HealthDay
15 October at 04.01 PM
FDA Approves Hympavzi for HemophiliaThe U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors.Unlike other drugs that replace a c |
HealthDay
15 October at 03.49 PM
Lithium Aspartate Not Effective for Neurologic Long COVID FatigueLithium aspartate is not effective for neurologic post-COVID-19 condition (PCC) symptoms of fatigue and cognitive dysfunction, according to a study published online Oct. 2 in JAMA Network Open.Thomas Guttuso Jr., M.D., from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in Williamsville, New York, an |
HealthDay
15 October at 03.40 PM
15.5 Million Adults Had Current ADHD Diagnosis in 2023An estimated 15.5 million U.S adults had a current diagnosis of attention-deficit/hyperactivity disorder (ADHD) in 2023, according to research published in the Oct. 10 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Brooke S. Staley, Ph.D., from the CDC in Atlanta, and colleagues estim |
HealthDay
15 October at 12.32 PM
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for NowPharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.What prompted the FDA to reconsider its <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-pol |
HealthDay
11 October at 09.07 PM
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic DiseasesFor patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual care, according to a study published online Oct. 11 in the Journal of the American Medical Association.Niklas Dyrby Johansen, M.D., Ph.D., from Copenhagen University Hospital -- Herlev a |
HealthDay
11 October at 03.53 PM
Industry Payments Common for Physician Peer Reviewers of Top JournalsMore than half of U.S. physician peer reviewers for the most influential medical journals receive industry payments, according to a research letter published online Oct. 10 in the Journal of the American Medical Association.David-Dan Nguyen, M.P.H., from the University of Toronto, and colleagues characterized payments by drug and m |
HealthDay
11 October at 03.51 PM
Benzene Exposure Results From Benzoyl Peroxide Drug Product UsePotential benzene exposure occurs as a result of benzoyl peroxide (BPO) drug product use, according to a study published online Oct. 7 in the Journal of Investigative Dermatology.The carcinogen benzene is a degradation product of BPO and has been reported to form when BPO drug products are incubated at body temperature and elevated temp |
HealthDay
11 October at 03.36 PM
Lentiviral Gene Therapy Beneficial for Early Cerebral AdrenoleukodystrophyFor boys with early-stage cerebral adrenoleukodystrophy and evidence of active inflammation, lentiviral elivaldogene autotemcel (eli-cel) gene therapy offers lasting benefits, according to a study published in the Oct. 10 issue of the New England Journal of Medicine.Florian Eichler, M.D., from Massachusetts General Hospital and Harvard |
HealthDay
10 October at 03.27 PM
Availability, Timeliness of Availability of New Cancer Drugs VaryAcross countries, there are considerable disparities in the availability and timeliness of availability of new cancer drugs, according to a study published online Oct. 8 in BMJ Global Health.Meng Li, Ph.D., from Tufts Medical Center in Boston, and colleagues examined the availability and timeliness of availability of new cancer drugs |
HealthDay
09 October at 10.16 PM
Antidepressant Warnings Had Unintended Impact on Youth Mental HealthYouth antidepressant warnings had a detrimental unintended effect: significant reductions in mental health care, according to a report published in the October issue of Health Affairs.Noting that since 2003 the U.S. Food and Drug Administration has warned that antidepressants may be associated with suicidal thoughts and behaviors amon |
HealthDay
09 October at 03.59 PM
Lamotrigine, Mexiletine Show Similar Benefits for Nondystrophic MyotoniasImprovements in nondystrophic myotonias symptoms are similar for lamotrigine and mexiletine, according to a study published in the October issue of The Lancet Neurology.Vinojini Vivekanandam, Ph.D., from the Centre for Neuromuscular Disorders at the National Hospital for Neurology and Neurosurgery in London, and colleagues random |
HealthDay
09 October at 03.51 PM
Dronabinol Safe, Effective for Alzheimer Disease With AgitationDronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a study presented at the annual meeting of the International Psychogeriatric Association, held from Sept. 25 to 27 in Buenos Aires, Argentina.Paul Rosenberg, M.D., from Johns Hopkins University School of Medicine in Baltimore, and col |
HealthDay
09 October at 03.38 PM
Most Pediatric Opioid Exposures Occur in Young Child's HomeNine in 10 pediatric opioid exposures occur unintentionally in the home, according to a brief report published online Aug. 14 in The Journal of Pediatrics.Perry E. Rosen, from the New Jersey Poison Information and Education System in Newark, and colleagues analyzed 230 pediatric opioid exposures (among children aged 1 month through 6 |
HealthDay
08 October at 04.12 PM
Social Risk Factors Tied to Lower Odds of Receiving Preventive ServicesSocial risk factors are associated with decreased odds of receiving preventive services such as mammograms, Papanicolaou (Pap) tests, flu or pneumococcal vaccines, and colonoscopies, according to a study published online Oct. 4 in JAMA Network Open.Tamara Schroeder, M.D., from the University of California, Davis, and colleagues exa |
HealthDay
08 October at 04.05 PM
Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple MyelomaCiltacabtagene autoleucel (cilta-cel) CAR T-cell therapy for relapsed/refractory multiple myeloma (RRMM) results in a deep and durable response, according to a study published online Oct. 4 in Blood.Surbhi Sidana, M.D., from Stanford University in California, and colleagues reported outcomes with cilta-cel in the standard-of-care s |
HealthDay
08 October at 03.54 PM
Many Patients Expecting Antibiotics for Common Symptoms Lack Knowledge of RiskLack of knowledge of antibiotic risks contributes to primary care patients' expectations of antibiotics for common symptoms, according to a study published online in the September/October issue of the Annals of Family Medicine.Lindsey A. Laytner, Ph.D., from the Baylor College of Medicine in Houston, and colleagues conducted a surv |
HealthDay
07 October at 09.21 PM
Metabolic Risk Contributes to Diabetes Onset in People With HIVFor people with HIV (PWH) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among those treated with pitavastatin or placebo, according to a study published online Oct. 8 in the Annals of Internal Medicine.Kathleen V. Fitch, from Massachusetts G |
HealthDay
07 October at 04.08 PM
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two DosesA one-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a two-dose program, according to a study published online Oct. 7 in CMAJ, the journal of the Canadian Medical Association.Mélanie Drolet, Ph.D., from the Université Laval in Québec City, and colleagues used an individ |
HealthDay
07 October at 04.02 PM
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis SuppurativaFor patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Christos C. Zouboulis, from the European Hidradenitis Suppurativa Foundation in Dessau, Germany, and |
HealthDay
07 October at 03.53 PM
Liso-Cel Has Favorable Safety Profile for Outpatients With Large B-Cell LymphomaFor patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen receptor T-cell product, lisocabtagene maraleucel (liso-cel), is safe for outpatients and inpatients and is efficacious, according to a study published online Sept. 30 in Blood Advances.Yuliya Linhares, M.D., from the |
HealthDay
07 October at 03.47 PM
CHEST: Dupilumab for COPD Tied to Improvement in Health-Related Quality of LifeDupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation, according to a study presented at CHEST 2024, the annual meeting of the American College of Chest Physicians, held from Oct. 6 to 9 in Boston. Surya P. Bhatt, M.D., from the University of Alabama at |
HealthDay
04 October at 09.15 PM
Immunity From Mpox Vaccine May Be WaningImmunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) vaccine, according to a research letter published online Oct. 3 in the Journal of the American Medical Association.Ai-ris Y. Collier, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues as |
HealthDay
04 October at 03.27 PM
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe EczemaFor patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Diamant Thaçi, Ph.D., from University Lübeck in Germany, and colleagues reported long-term efficacy and |
HealthDay
04 October at 03.18 PM
GLP-1 RA Use Linked to Retained Gastric Contents During EndoscopiesUse of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, according to a research letter published online Oct. 1 in JAMA Network Open.Jason Nasser, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagu |
HealthDay
04 October at 03.15 PM
Anti-TL1A Monoclonal Antibody, Tulisokibart, Aids Ulcerative ColitisTulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission in patients with moderately to severely active ulcerative colitis than placebo, according to a phase 2 study published in the Sept. 26 issue of the New England Journal of Medicine.Bruce E. Sands, M.D., from th |
HealthDay
03 October at 10.14 PM
CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable DangerCounterfeit medications from online pharmacies pose significant risks to patients, including overdose and death, according to a warning issued by the U.S. Centers for Disease Control and Prevention.The warning follows a federal indictment announced last week again |
HealthDay
03 October at 03.40 PM
Rheumatoid Arthritis Tied to Heavy Economic and Human BurdensRheumatoid arthritis (RA) is associated with higher health care expenditures and suboptimal quality of life in U.S. adults, according to a study published online Aug. 6 in ACR Open Rheumatology.Yinan Huang, Ph.D., from the University of Mississippi in Oxford, and colleagues estimated the economic and humanistic burden of RA among |
HealthDay
03 October at 11.18 AM
Record Rate of U.S. Kindergartners Failed to Get Recommended VaccinesIn yet another sign that childhood vaccinations can't be taken for granted, new government data show that a record number of kindergartners were exempted from the required shots during the last school year.That leaves more than 125,000 new students without the protection of at least one childhood vaccine, even as measles vaccination rates among |
HealthDay
02 October at 03.11 PM
Olanzapine, Prochlorperazine Both Alleviate Refractory Chemo-Related NauseaOlanzapine may be better than prochlorperazine for reducing refractory nausea in patients with breast cancer starting a high/moderate emetogenic chemotherapy regimen, according to a study presented at the American Society of Clinical Oncology annual Quality Care Symposium, held from Sept. 27 to 28 in San Francisco. Luke Joseph Peppone, Ph |
HealthDay
02 October at 02.54 PM
Higher Buprenorphine Doses Reduce Acute Care for Opioid Use DisorderHigher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization, according to a study published online Sept. 25 in JAMA Network Open.Sarah Axeen, Ph.D., from the University of Southern California in Los Angeles, and colleagues examined the association between higher bupre |
HealthDay
02 October at 02.51 PM
First-Trimester Iron Screening Can ID Women at Risk for Later DeficiencyScreening pregnant women during their first trimester with a target ferritin concentration of >60 μg/L may identify those at risk for iron deficiency later in pregnancy, according to a study published online Sept. 26 in the American Journal of Clinical Nutrition.Elaine K. McCarthy, Ph.D., from University College Cork in Irelan |
HealthDay
01 October at 10.48 PM
FDA Approves Dupixent for Chronic Obstructive Pulmonary DiseaseThe U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.The approval was based on results from two pivotal phase 3 trials (BOREAS and NOTUS) that evaluated Dupixent (468 and 470 par |
HealthDay
01 October at 10.45 PM
2023 Cisplatin Shortage Tied to Use of Alternatives for Head, Neck CancerThe 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presented at the American Society of Clinical Oncology annual Quality Care Symposium, held from Sept. 27 to 28 in San Francisco.Puneeth Indurlal, M.D., from the U.S. Onco |
HealthDay
30 September at 10.15 PM
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type CThe U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, in combination with the enzyme inhibitor miglustat, is approved to treat neurological symptoms associated with NPC in adults and children aged 2 years and older. The approval received pr |
HealthDay
30 September at 04.14 PM
Guideline Developed for Opioid Prescribing in Children With Acute PainIn a clinical practice guideline issued by the American Academy of Pediatrics and published online Sept. 30 in Pediatrics, recommendations are presented for opioid prescribing for acute pain management in children and adolescents in outpatient settings.Scott E. Hadland, M.D., M.P.H., from Harvard Medical School in Boston, and colleague |
HealthDay
30 September at 04.09 PM
Event-Free Survival Extended With Long-Term Finerenone in Heart FailureLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief report published online Sept. 27 in JAMA Cardiology to coincide with the annual meeting of the Heart Failure Society of America, held virtually from Sept. 27 to |
HealthDay
30 September at 04.04 PM
Measles Cases in England Consistent With Waning of Vaccine ImmunityMeasles cases in England are consistent with the waning of vaccine-induced immunity, according to a study published online Sept. 26 in The Lancet Public Health.Alexis Robert, Ph.D., from the London School of Hygiene & Tropical Medicine, and colleagues examined whether measles dynamics observed in England between 2010 and 2019 were |
HealthDay
30 September at 04.01 PM
1999 to 2020 Saw Decline in Menopausal Hormone Therapy UseFrom 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health Forum.Lin Yang, Ph.D., from Cancer Care Alberta in Calgary, Canada, and colleagues examined trends in and correlates of MHT use among postmenopausal women in the Unite |
HealthDay
27 September at 10.41 PM
More Than Half of Infants Protected by Maternal RSV Vaccine, Nirsevimab, or BothIn the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV vaccine, nirsevimab, or both, according to research published in the Sep. 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Hilda Razzaghi, Ph.D., from the CDC in Atl |
HealthDay
27 September at 04.03 PM
Metabolic Surgery Is Renoprotective in Patients With Obesity, CKDFor patients with obesity, type 2 diabetes, and estimated glomerular filtration rate (eGFR) 20 to 60 mL/min/1.73 m2, metabolic surgery is associated with a lower risk for progression of kidney impairment compared with glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment, according to a study published in the September issue of the < |
HealthDay
27 September at 04.00 PM
Aggressive, Early Disease-Modifying Therapy May Slow MS ProgressionReducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression, according to a study presented at the annual meeting of the American Neurological Association, held Sept. 14 to 17 in Orlando, Florida.Jack Reeves, Ph.D., from State University of New York at Buffalo, and colleagues assessed the |
HealthDay
27 September at 03.52 PM
Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With RSVFor infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 issue of the New England Journal of Medicine.Shunying Zhao, M.D., Ph.D., from Beijing Children's Hospital, and colleagues enrolled participan |
HealthDay
27 September at 10.19 AM
FDA Approves New Kind of Drug for SchizophreniaThe first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.Cobenfy (xanomeline/trospium chloride) could bring patients what they've long hoped for: A means of easing the hallucinations and "voices" that disrupt their lives without the weight gain and sluggish |
HealthDay
26 September at 10.28 PM
Childhood Vaccination Coverage Lower for Children Born in 2020, 2021Children born in 2020 to 2021 had lower coverage with nearly all childhood vaccines recommended by age 24 months than those born in 2018 and 2019, according to research published in the Sep. 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Holly A. Hill, M.D., Ph.D., from the CDC i |
HealthDay
26 September at 10.27 PM
Free COVID-19 Tests Available NowThe free COVID-19 tests promised by the U.S. government are now available."U.S. households will be eligible to order four free COVID-19 tests at COVIDTests.gov," according to the U.S. Department of Health and Human Services. "The COVID-19 tests will detect current COVID-19 variants and can be used through the end of the year."More than |
HealthDay
26 September at 04.22 PM
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MSThe U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis (MS).The injection is administered by a health care professional. Patients are given premedications at least 30 |
HealthDay
26 September at 04.01 PM
FDA Approves Bimzelx for Three New IndicationsThe U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, and adults with active ankylosing spondylitis (AS).Bimzelx selectively inhibits two key cyt |
HealthDay
26 September at 03.38 PM
Anti-CD20 Therapy Shows No Effect on Disability Progression in MSFor patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-treated and untreated, according to a study published online Sept. 25 in Neurology.Marion Hay, M.D., from Rennes University Hospital in France, and colleagues analyzed CDP in |
HealthDay
25 September at 10.25 PM
Federal Government to Offer More Free COVID-19 TestsThe U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September."U.S. households will be eligible to order four free COVID-19 tests at COVIDTests.gov," according to the U.S. Department of Health and Human Services. "The COVID-19 tests will detect current COVID-19 variants and can be used |
HealthDay
25 September at 03.47 PM
Semaglutide May Lower Risk for Opioid Overdose in T2DM, Opioid Use DisorderFor patients with type 2 diabetes (T2D) and opioid use disorder (OUD), semaglutide is associated with a significantly lower risk for opioid overdose compared with other antidiabetic medications, according to a research letter published online Sept. 25 in JAMA Network Open.William Wang, from the Case Western Reserve University School |
HealthDay
25 September at 03.42 PM
Early Adoption of DOAC Dashboard Reduces Off-Label PrescribingEarly adoption of the direct oral anticoagulant (DOAC) population management dashboard, the purpose of which includes pharmacist review and correction of off-label dosing prescriptions, is associated with reduced rates of off-label DOAC dosing prescription and reduced bleeding, according to a study published online Sept. 9 in the Journal of the |
HealthDay
25 September at 03.40 PM
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With ObesityFor patients with obesity, the addition of semaglutide to standard hidradenitis suppurativa (HS) treatments yields improvement in quality of life and a reduction in flares, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. 25 to 28 in Amsterdam.Daniel Lyons, M.D., fro |
HealthDay
25 September at 01.00 PM
Most Americans Won't Get Vaccinated as Flu, COVID Season Looms: SurveyMost Americans don’t plan to get vaccinated against the flu or COVID-19 this season, a new survey has found.Fewer than two in five U.S. adults (38%) say they will definitely get a flu jab, and only one in four (26%) say they’ll get the updated COVID v |
HealthDay
25 September at 11.31 AM
Novo Nordisk CEO Grilled by Congress Over Price of OzempicDuring a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.While testifying before the Senate Commit |
HealthDay
24 September at 11.00 PM
Few U.S. Jails Offer Medications for Opioid Use DisorderFew U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA Network Open.Elizabeth Flanagan Balawajder, M.P.H., from NORC at the University of Chicago, and colleagues examined the prevalence of MOUD in U.S. jails and the association of jail- and county-level factors with MOUD |
HealthDay
24 September at 10.58 PM
14 Percent of U.S. Adults Meet Criteria for Absolute Iron DeficiencyA considerable proportion of U.S. adults has absolute and functional iron deficiency, according to a study published online Sept. 24 in JAMA Network Open.Yahya M.K. Tawfik, Pharm.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a cross-sectional study analyzing data from the National Health and Nutritional Exa |
HealthDay
24 September at 03.07 PM
Skeletal Muscle Relaxants Beneficial for Only Certain ConditionsLong-term use of skeletal muscle relaxants (SMRs) for chronic pain is only effective for certain conditions, such as painful spasms, painful cramps, and neck pain, according to a review published online Sept. 19 in JAMA Network Open.Benjamin J. Oldfield, M.D., from the Yale School of Medicine in New Haven, Connecticut, and collea |
HealthDay
24 September at 03.03 PM
UBE Microdiscectomy Beneficial for Lumbar Disc HerniationFor adults with symptomatic lumbar disc herniation, unilateral biportal endoscopic (UBE) microdiscectomy is associated with longer operating times and with lower pain medication consumption in the early postoperative period compared with tubular lumbar microdiscectomy, according to a study published online Sept. 19 in Blood.Charla Fis |
HealthDay
23 September at 10.26 PM
Review Compares Drug Interventions for Acute Migraine TreatmentAll active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults, according to a review published online Sept. 18 in The BMJ.William K. Karlsson, from the Danish Headache Centre at Copenhagen University Hospital-Rigshospitalet |
HealthDay
23 September at 03.53 PM
Pomalidomide Efficacious in Hereditary Hemorrhagic TelangiectasiaFor patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the Sept. 19 issue of the New England Journal of Medicine.Hanny Al-Samkari, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a randomized, place |
HealthDay
23 September at 03.50 PM
High Response Incidence Seen for Axatilimab in Recurrent, Refractory GVHDFor patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor (CSF1R)-blocking antibody axatilimab results in a high incidence of overall response, according to a study published in the Sept. 19 issue of the New England Journal of Medicine.Daniel Wolff, M.D., from University Hospit |
HealthDay
23 September at 03.42 PM
Paternal Antiseizure Rx Use at Conception Does Not Pose Risk to OffspringLimited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according to a review published online Sept. 17 in the Journal of Neurology, Neurosurgery & Psychiatry.Eliza Honybun, from the University of Melbourne in Australia, and |
HealthDay
20 September at 10.59 PM
No Perinatal Risks Seen With Influenza Vaccination in Successive PregnanciesInfluenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes, according to a study published online Sept. 19 in JAMA Network Open.Darios Getahun, M.D., Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues conducted a retrospective coho |
HealthDay
20 September at 10.58 PM
FDA Approves First Flu Vaccine That Can Be Self-Administered at HomeOn Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home.It is a "new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility, and accessibility for individuals and families," Peter Marks, M.D., director of the FDA Center fo |
HealthDay
20 September at 03.58 PM
In 2021, More Than 1 Million Deaths Attributed to Antimicrobial ResistanceFrom 1990 to 2021, the burden of antimicrobial resistance (AMR) decreased for those younger than 5 years and increased for those older than 70 years, according to a study published online Sept. 16 in The Lancet.Mohsen Naghavi and colleagues from the GBD 2021 Antimicrobial Resistance Collaborators estimated all-age and age-specific deat |
HealthDay
20 September at 03.50 PM
Behavior Change Intervention Via Mail Cuts Use of Sleep Medications in Older AdultsA mailed knowledge mobilization and behavior change intervention can reduce the use of sedatives and improve sleep outcomes in older adults with insomnia, according to a study published online Sept. 18 in JAMA Psychiatry.David M. Gardner, Pharm.D., from Dalhousie University in Halifax, Nova Scotia, Canada, and colleagues compared |
HealthDay
20 September at 03.42 PM
Tivozanib Has Efficacy in Advanced Renal Cell Carcinoma Post-ICI TherapyFor patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, including one immune checkpoint inhibitor (ICI), tivozanib has efficacy, according to a study published online Sept. 13 in The Lancet to coincide with the annual meeting of the European Society for Medical Oncology, held |
HealthDay
20 September at 03.29 PM
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial CancerDisease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk muscle-invasive urothelial carcinoma after radical surgery, according to a study published online Sept. 18 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncol |
HealthDay
20 September at 12.06 PM
FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced.Known as TIRF medications, these products contain fentanyl and are used to manage breakthrough pain in cancer patients who have become tolerant to around-the-clock opioid therapy, the FDA said in a <a |
HealthDay
20 September at 11.15 AM
U.S. Whooping Cough Cases Rising, Especially in Teens, CDC SaysWhooping cough cases are climbing at the fastest pace in years as students across America return to school, U.S. health officials reported Thursday.In figures published by the U.S. Centers for Disease Control and Prevention, a total of 291 cases were reported |
HealthDay
19 September at 10.12 PM
Improvement Seen in Vaccine Completion Among Military ChildrenAmong military children, there has been an improvement in vaccine completion and timeliness, but the risk for noncompletion is higher among children born to younger parents and those with a well-child care location change, according to a study published online Sept. 19 in Pediatrics.Celeste J. Romano, from the Naval Health Research C |
HealthDay
19 September at 10.10 PM
Pembrolizumab + Chemo Beneficial for Early-Stage Triple-Negative Breast CancerFor patients with early-stage triple-negative breast cancer, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab yields a significant improvement in overall survival compared with neoadjuvant chemotherapy alone, according to a study published online Sept. 15 in the New England Journal of Medicine to coincide with |
HealthDay
19 September at 03.57 PM
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC), according to a study published online Sept. 17 in Diabetes Care.Steven G. Johnson, Ph.D., from the University of Minnesota in Minneapo |
HealthDay
19 September at 03.51 PM
Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked MyocarditisCOVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of eClinicalMedicine.Supriya S. Jain, M.D., from New York Medical College-Maria Fareri Children's Hospital at Westchester Medical Center in Valhalla, and colle |
HealthDay
19 September at 03.35 PM
Adjuvant Durvalumab Extends Survival in Small Cell Lung CancerFor patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to a study published online Sept. 13 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from Sept. |
HealthDay
19 September at 03.31 PM
Long-Term Survival Benefit Seen for Nivolumab in Advanced MelanomaFor patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy, according to a study published online Sept. 15 in the New England Journal of Medicine to coincide with the annual meeting of the European Society for Medical Oncology, held from S |
HealthDay
18 September at 10.22 PM
FDA Approves Ebglyss for Moderate-to-Severe Atopic DermatitisThe U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.The targeted interleukin-13 inhibitor is administered via a 250-mg/2 mL injection with or without topical corticosteroids in patients with atopic dermatitis not well controll |
HealthDay
18 September at 03.46 PM
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic MigraineMonthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine (CM) and MOH, according to a study published online Sept. 16 in JAMA Neurology.Stewart J. Tepper, M.D., from the New England Institute for Neurology and Headache in St |
HealthDay
18 September at 03.41 PM
Discrepancies Seen Between Young People's Preferred, Actual Sources of Contraceptive InfoThere are discrepancies between preferred and actual sources of contraceptive information for U.S. adolescents and young adults (AYA), according to a research letter published online Sept. 13 in JAMA Network Open.Elizabeth Pleasants, Dr.P.H., from the University of California, Berkeley, and colleagues examined AYAs’ preferred a |
HealthDay
18 September at 11.05 AM
FDA Expands Use of Breast Cancer Drug KisqaliWomen with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment, drug maker Novartis announced Tuesday.“The FDA approval of Kisqali for this early breast cancer p |
HealthDay
18 September at 09.48 AM
Cost Has Many Going Around Doctors to Get Weight-Loss MedicationsWegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, and often too expensive to afford without insurance coverage.Because of these barriers, many people are doing an end-run around t |
HealthDay
17 September at 09.20 PM
Postpartum Anxiety, Depression Not Up After Pandemic Onset, but Benzodiazepine Rx IncreasedAmong privately insured women, diagnoses of postpartum anxiety and depression did not increase following onset of the COVID-19 pandemic, but there was an increase in the proportion of women filling a benzodiazepine prescription, according to a study published online June 24 in the Archives of Women's Mental Health.Grace Bagwell Adams, |
HealthDay
17 September at 09.13 PM
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer PatientsFor postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with the risk for coronary artery calcium (CAC), according to a study published online Sept. 17 in the Canadian Journal of Cardiology.Yu Hiasa, M.D., from the Ehime University Graduate School of Medicine in Toon, Japan, |
HealthDay
17 September at 03.23 PM
Rx Amphetamine Use Linked to Increased Odds of Psychosis, ManiaPast-month prescription amphetamine use is associated with increased odds of psychosis and mania, with increased odds for high doses (>30 mg dextroamphetamine equivalents), according to a study published online Sept. 12 in The American Journal of Psychiatry.Lauren V. Moran, M.D., M.P.H., from McLean Hospital in Belmont, Massachuset |
HealthDay
17 September at 03.05 PM
One-Dose MVA-BN Vaccine Moderately Effective Against MpoxOne dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities, according to a study published online Sept. 11 in The BMJ.Christine Navarro, M.D., from Public Health Ontario in Toronto, and colleagues estimated the real-world effectiveness of the MVA-BN vacci |
HealthDay
17 September at 02.58 PM
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, DiabetesFor patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for cirrhosis and for cirrhosis complications and mortality, according to a study published online Sept. 16 in JAMA Internal Medicine.Fasiha Kanwal, |
HealthDay
16 September at 10.23 PM
FDA Approves Tremfya for Ulcerative ColitisThe U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.Tremfya is the first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis. It is approved for administration as a 200-mg induction dose intravenously at weeks 0, |
HealthDay
16 September at 03.45 PM
Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased, according to a study published online Sept. 13 in JAMA Network Open.Ashwini Nagappan, from University of California, Los Angeles, and colleagues characterized in-person and telehea |
HealthDay
13 September at 03.35 PM
Once-Weekly Efsitora Noninferior to Degludec for Type 2 DiabetesOnce-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2 diabetes who have not received insulin, according to a study published online Sept. 10 in the New England Journal of Medicine to coincide with the annual meeting of the European Association for the Study of Diabetes, held f |
HealthDay
13 September at 02.44 PM
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLCTusamitamab ravtansine (tusa rav), an immunoconjugate, does not improve progression-free survival (PFS) in patients with previously treated advanced nonsquamous non-small cell lung cancer (NSCLC), according to a study presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer, held from Sept. 7 to 10 i |
HealthDay
13 September at 02.38 PM
Many U.S. Adults With Uncontrolled HTN Are Unaware of HTN StatusMore than half of adults with uncontrolled hypertension are unaware that they have hypertension, according to a study published online Sept. 11 in JAMA Network Open.LaTonia C. Richardson, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined the prevalence of hypertension control cascade ou |
HealthDay
12 September at 09.31 PM
Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal CancerFor patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is the preferred total neoadjuvant therapy (TNT) regimen, according to a study published online Sept. 11 in the Annals of Oncology to coincide with the European Society for Medical Oncology Congress 2024, being held from Sept. |
HealthDay
12 September at 04.18 PM
2017 to 2022 Saw Increase in Naloxone Prescribing Among AdolescentsFrom 2017 to 2022, there was an increase in naloxone prescribing among adolescents, with pediatricians accounting for an increasing proportion of prescriptions dispensed, according to a study published online Sept. 12 in Pediatrics.Andrew Terranella, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, a |
HealthDay
12 September at 04.14 PM
Liraglutide Efficacious, Safe for Children Aged 6 to <12 YearsLiraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study published online Sept. 10 in the New England Journal of Medicine to coincide with the European Association for the Study of Diabetes Congress, held Sept. 9 to 13 in Madrid.Claudia K. Fox, M.D., from the Univer |
HealthDay
12 September at 04.10 PM
Racial Differences Seen in Pain Rx for Older Adults With Hip FractureRacial differences exist in opioid pain management for Medicare beneficiaries after a hip fracture, according to a study published online Sept. 11 in the Journal of the American Geriatrics Society.Kaleen N. Hayes, Pharm.D., Ph.D., from Brown University in Providence, Rhode Island, and colleagues assessed whether the receipt and |
HealthDay
12 September at 03.59 PM
Perioperative Nivolumab Beneficial for Resectable NSCLCFor patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free survival (EFS) benefit compared with neoadjuvant nivolumab, according to a study presented at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer, held from Sept. 7 to 10 in San Diego. |
HealthDay
12 September at 03.51 PM
Statin Therapy Cost-Effectively Improves Health Outcomes for ≥70sStatin therapy improves health outcomes and is cost-effective for men and women aged 70 years and older, according to a study published online Sept. 10 in Heart.Borislava Mihaylova, D.Phil., from the University of Oxford in the United Kingdom, and colleagues examined the long-term effects and cost-effectiveness of statin therapy for |
HealthDay
12 September at 09.47 AM
Many Americans Wary of Vaccines as Fall Flu, COVID Season Looms: SurveyA lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds.More than one-third of those polled (37%) said they’d gotten vaccines in the past but don’t plan to this year, according to results from a nationwide Ohio State |
HealthDay
11 September at 03.40 PM
Quadruple Single Pill Superior for Resistant HypertensionFor patients with resistant hypertension, a quadruple single pill is superior to triple therapy, according to a study presented at the European Society of Cardiology Congress, held from Aug. 30 to Sept. 2 in London.Stefano Taddei, from the University of Pisa in Italy, and colleagues conducted a double-blind, randomized trial involving patien |
HealthDay
11 September at 03.36 PM
Use of Nose Drops Reduces Length of Young Children’s ColdsHypertonic saline (HS) nose drops reduce the duration of symptoms associated with viral upper respiratory tract infections (URTI) in children, according to a study presented at the European Respiratory Society Congress, held from Sept. 7 to 11 in Vienna.Steve Cunningham, from University of Edinburgh in Scotland, and colleagues investiga |
HealthDay
11 September at 03.33 PM
Many Women Continue Using Menopausal Hormone Therapy Beyond Age 65 YearsMany women older than 65 years have validated menopausal symptoms severely affecting their quality of life and continue to use menopausal hormone therapy (MHT), according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.Meenakshi Goel, M.D., from University of Toronto, and colleagues ex |
HealthDay
11 September at 03.27 PM
Hormone Tx Tied to Reductions in Insulin ResistanceHormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.Tanya Li, from Reading Hospital Tower Health in West Reading, Pennsylvania, and colleagues conducted a systematic |
HealthDay
10 September at 10.32 PM
2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage RatesMenopausal hormone therapy (HT) usage rates declined from 2007 to 2023 and remain low, according to a study presented at the annual meeting of The Menopause Society, held from Sept. 10 to 14 in Chicago.Mariam Saadedine, M.D., from the Mayo Clinic in Jacksonville, Florida, and colleagues described systemic menopausal HT utilization in women age |
HealthDay
10 September at 10.19 PM
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced CancerOmission of 5-fluorouracil (5-FU) from the first-line FOLFOX, FOLFIRI, and FOLFIRINOX regimens is not associated with reduced survival among patients with advanced colorectal, gastroesophageal, and pancreatic cancers, according to a study published online Sept. 5 in the Journal of the National Comprehensive Cancer Network.Chengwei Pen |
HealthDay
10 September at 10.13 PM
Depemokimab Cuts Exacerbation Rate in Eosinophilic AsthmaFor patients with severe asthma with an eosinophilic phenotype, depemokimab reduces the annualized rate of exacerbations, according to a study published online Sept. 9 in the New England Journal of Medicine to coincide with the European Respiratory Society Congress, held from Sept. 7 to 11 in Vienna.David J. Jackson, Ph.D., from King' |
HealthDay
10 September at 04.00 PM
Low-Dose Triple-Pill Protocol Lowers BP in Black Africans With HypertensionFor Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure lowering and control than standard care, according to a study published online Aug. 31 in the Journal of the American Medical Association to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30 |
HealthDay
10 September at 03.45 PM
Timing of Blood Pressure Meds Has No Impact on OutcomesTaking blood pressure (BP) medications in the morning or at night does not impact outcomes, according to a study presented at the annual meeting of the European Society of Cardiology, held Aug. 30 to Sept. 2 in London.Scott Garrison, M.D., Ph.D., from University of Alberta in Edmonton, Canada, and colleagues evaluated whether bedtime use of BP |
HealthDay
10 September at 03.35 PM
Review Weighs Treatments for Genitourinary Symptoms of MenopauseVaginal estrogen, vaginal dehydroepiandrosterone (DHEA), oral ospemifene, and vaginal moisturizers may be beneficial for some genitourinary symptoms of menopause (GSM), according to a review published online Sept. 10 in the Annals of Internal Medicine.Elisheva R. Danan, M.D., M.P.H., from the University of Minnesota in Minneapolis, an |
HealthDay
09 September at 03.56 PM
Polypharmacy Common in Medicaid-Enrolled Youth With Behavioral and Mental Health DiagnosesContraindicated drug pairs are uncommon in youth with Medicaid coverage filling combinations of behavioral and mental health (BMH) medications, according to a study published online July 30 in BMC Primary Care.Laura M. Borgelt, Pharm.D., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues characterized |
HealthDay
09 September at 03.45 PM
Empagliflozin Confers Kidney-Protective Benefits After Acute MIEmpagliflozin confers kidney-protective benefits for patients with acute myocardial infarction (MI) and an increased risk for heart failure, according to a study presented at the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in London.Rahul Aggarwal, M.D., from Harvard Medical School in Boston, and colleagues conduct |
HealthDay
06 September at 09.57 PM
6.7 Percent of U.S. Adults Cannot Use Automatic BP Devices Due to Arm SizeAn estimated 6.7 percent of U.S. adults cannot use popular automatic blood pressure devices due to arm circumference, according to a research letter published online Sept. 5 in Hypertension to coincide with the American Heart Association Hypertension 2024 Scientific Sessions, held from Sept. 5 to 8 in Chicago.Eileen Kaur, from |
HealthDay
06 September at 09.37 PM
Socioeconomic Disparities Impact Immunotherapy Use in Urologic CancersImmunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell carcinoma (ccRCC) and urothelial carcinoma of the bladder (UC), according to a study published in the November issue of Urologic Oncology: Seminars and Original Investigations.Levi Holl |
HealthDay
06 September at 03.45 PM
Machine Learning Can ID Risk for Persistent Opioid Use After SurgeryMachine learning can identify patients who are at risk for persistent opioid use after surgery, according to a study published in the September issue of Plastic and Reconstructive Surgery.Natalie B. Baxter, from the University of Michigan Medical School in Ann Arbor, and colleagues trained two algorithms to predict persistent opioid use |
HealthDay
06 September at 03.09 PM
Adjunctive IV Argatroban, Eptifibatide Do Not Cut Disability After StrokeAdjunctive treatment with intravenous argatroban or eptifibatide does not reduce poststroke disability among patients with acute ischemic stroke treated with intravenous thrombolysis within three hours after symptom onset, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Opeolu Adeoye, M.D., fro |
HealthDay
05 September at 10.41 PM
Lower Uptake of HPV Vaccine Seen for Girls With Mental IllnessGirls with mental illness and neurodevelopmental conditions have lower uptake of human papillomavirus (HPV) vaccination, according to a study published in the September issue of The Lancet Public Health.Kejia Hu, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study to examine the |
HealthDay
05 September at 10.38 PM
Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic LeiomyosarcomaFor patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, according to a study published online Sept. 4 in the New England Journal of Medicine.Patricia Pautier, M.D., fro |
HealthDay
05 September at 10.35 PM
RSV Vaccination Effective Against Hospitalization in Patients 60 Years and OlderFor older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of the American Medical Association.Diya Surie, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined RSV vaccine effectiven |
HealthDay
05 September at 03.06 PM
Report Reveals Extent of Cost-Related Medication Nonadherence in SeniorsAbout 3.5 percent of older adults do not take prescription medications due to cost and a similar percentage do not take medications as prescribed due to cost, according to a study published online Sept. 5 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.Robin A. Cohen, Ph.D., |
HealthDay
05 September at 10.23 AM
Amid Shortages, U.S. Allows Expanded Production of ADHD Drug VyvanseThe maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.Following a request from the U.S. Food and Drug Administration in July, the DE |
HealthDay
04 September at 11.06 PM
Monoclonal Antibody Tops Placebo for Reducing Migraine FrequencyThe humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a study published in the Sept. 5 issue of the New England Journal of Medicine.Messoud Ashina, M.D., from Copenhagen |
HealthDay
04 September at 03.10 PM
First-Generation Antihistamines Increase Risk for Seizures in ChildrenFirst-generation antihistamines are associated with a higher seizure risk in young children, according to a study published online Aug. 28 in JAMA Network Open.Ju Hee Kim, M.D., from the Kyung Hee University Medical Center in Seoul, South Korea, and colleagues evaluated associations between prescriptions of first-generation anti |
HealthDay
04 September at 03.06 PM
Asthma Inhalers Tied to Large Greenhouse Gas Emissions ProductionInhaler devices are a substantial source of greenhouse gas emissions in the United States, according to a research letter published online Aug. 29 in the Journal of the American Medical Association.Jyothi Tirumalasetty, M.D., from the Stanford University School of Medicine in California, and colleagues assessed mean emissions in |
HealthDay
03 September at 08.11 PM
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European CountriesTime from approval to reimbursement of new drugs varies between countries and is shortest in Switzerland and Germany, both of which include health technology assessment decisions that are not used in the United States, according to a study published online Sept. 3 in the Annals of Internal Medicine.Camille E.G. Glaus, J.D., from the Un |
HealthDay
03 September at 08.11 PM
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With DiabetesSodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in The BMJ.Anna Shin, from Seoul National University Bundang Hospital in South Korea, and colleagues compared the risk for dementia associated with SGLT-2 inhibitors versus dipe |
HealthDay
03 September at 08.09 PM
Hormone Therapy Tied to Less Biological Aging in Postmenopausal WomenPostmenopausal women who use hormone therapy (HT) are biologically younger than those not receiving HT, according to a study published online Aug. 29 in JAMA Network Open.Yufan Liu and Chenglong Li, Ph.D., from Peking University in Beijing, evaluated the association between HT use and discrepancies between chronological and biolog |
HealthDay
30 August at 10.57 PM
Home Administration of Misoprostol Safe, EffectiveHome administration of misoprostol significantly increases the proportion of day-care procedures in medical abortion after 12 gestational weeks, according to a study published in the Aug. 31 issue of The Lancet.Johanna Rydelius, M.D., from the University of Gothenburg in Sweden, and colleagues evaluated whether administering the first m |
HealthDay
30 August at 03.06 PM
Dietary Vitamin E May Be Protective Against Atopic DermatitisDietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in Skin Research & Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary |
HealthDay
29 August at 03.59 PM
Naloxone Aids Out-of-Hospital Cardiac Arrest Outcomes, Regardless of Drug UseRegardless of drug use, administration of naloxone during out-of-hospital cardiac arrest (OHCA) is associated with improved outcomes, such as increased survival to hospital discharge, according to a study published online Aug. 20 in JAMA Network Open.David G. Dillon, M.D., Ph.D., from the University of California, Davis, and coll |
HealthDay
29 August at 03.56 PM
Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination MyocarditisPatients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months, according to a study published online Aug. 26 in the Journal of the American Medical Association.Laura Semenzato, from the French Natio |
HealthDay
29 August at 03.46 PM
People With Xylazine Wounds Face Barriers to Seeking Wound CarePeople with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und |
HealthDay
28 August at 10.04 PM
Ubrogepant Administered During Prodrome Beneficial for MigraineFor adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes, according to a study published online Aug. 28 in Neurology.Richard B. Lipton, M.D., from the Albert Einstein College of Medicine in Bronx, New York, and colleagues conduc |
HealthDay
28 August at 04.03 PM
RSV Infection With Inflammatory Bowel Disease Ups Risk for HospitalizationAdult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study published online in the August issue of The American Journal of Gastroenterology.Ryan A. Smith, M.D., from University of Wisconsin in Madison, and colleagu |
HealthDay
28 August at 03.54 PM
Psilocybin Has Better Response Than Placebo in Antidepressant TrialsPatients treated with high-dose psilocybin have better responses than those treated with placebo in antidepressant trials, according to a study published online Aug. 21 in The BMJ.Tien-Wei Hsu, M.D., from E-DA Dachang Hospital in Kaohsiung, Taiwan, and colleagues examined the comparative effectiveness and acceptability of oral monoth |
HealthDay
28 August at 03.04 PM
Cholinesterase Inhibitors Beneficial for Dementia With Lewy BodiesCholinesterase inhibitors (ChEIs) are beneficial for patients with dementia with Lewy bodies (DLB), according to a study published online Aug. 23 in Alzheimer's & Dementia.Hong Xu, M.D., Ph.D., from the Center for Alzheimer Research at the Karolinska Institutet in Stockholm, and colleagues examined the impact of ChEIs and memanti |
HealthDay
28 August at 03.02 PM
Increasing Thiazide Dose Linked to Greater Reduction in CalciumFor adults with kidney stones, increasing thiazide dose is associated with greater reductions in calcium, which are negatively associated with symptomatic stone events, according to a research letter published online Aug. 22 in JAMA Network Open.Ryan S. Hsi, M.D., from the Vanderbilt University Medical Center in Nashville, Tennessee, |
HealthDay
28 August at 02.58 PM
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart FailureSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and heart failure, according to a study published online Aug. 24 in The Lancet.John Deanfield, B.Chir., M.B., from the Institute of Cardiovascular Sciences at |
HealthDay
27 August at 09.55 PM
Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care ProvidersCounties with high pharmacy desert densities also face social vulnerability and health care provider shortages, according to a research letter published online Aug. 23 in JAMA Network Open.Giovanni Catalano, M.D., from The Ohio State University Wexner Medical Center in Columbus, and colleagues examined if pharmacy deserts dispropo |
HealthDay
27 August at 09.47 PM
FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 DiabetesOn Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by people with the more prevalent form of the disease.The FDA first signed off on the system, which automatically adjusts insulin delivery as needed, for type 1 diabetes i |
HealthDay
27 August at 03.55 PM
Lecanemab-Labeled Amyloid Plaques Identified in Down SyndromeIn middle-aged individuals with Down syndrome (DS), lecanemab-labeled amyloid plaques are seen in postmortem brain tissue analysis, in addition to extensive binding to brain blood vessels, according to a study published online Aug. 19 in JAMA Neurology.Lei Liu, M.D., Ph.D., from Brigham and Women's Hospital in Boston, and colleagues ex |
HealthDay
27 August at 03.42 PM
Elinzanetant Efficacious, Well-Tolerated for Vasomotor SymptomsFor menopausal vasomotor symptoms (VMS), elinzanetant is efficacious and well-tolerated, according to a study published online Aug. 22 in the Journal of the American Medical Association.JoAnn V. Pinkerton, M.D., from the University of Virginia Health in Charlottesville, and colleagues examined the efficacy and safety of elinzanetant, a |
HealthDay
27 August at 02.12 PM
Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the PriceEli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and co |
HealthDay
27 August at 10.57 AM
WHO Unveils Plan to End African Mpox OutbreakAs an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread.“The mpox outbreaks in the Democratic Republic of the Congo and neighboring countries can be controlled, and can be stopped,” WHO Director-General <a href="https://blogs.worldbank.org/en/team/t/tedros-adhanom-gh |
HealthDay
26 August at 09.50 PM
After Weighting, 3.6 Million Likely to Be Newly Eligible for SemaglutideIncreases in eligibility for semaglutide are discussed in a research letter published online Aug. 27 in the Annals of Internal Medicine.After the Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity trial showed that semaglutide reduced cardiovascular events in certain patients without diabetes, Medicar |
HealthDay
26 August at 09.45 PM
Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DMFor older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study published online Aug. 27 in the Annals of Internal Medicine.Bin Hong, from the School of Pharmacy at Sungkyunkwan |
HealthDay
26 August at 09.19 PM
Most Americans Unprepared to Handle Opioid OverdosesMore than three in four people (77 percent) say they would not know how to respond if they saw someone having an opioid overdose, according to survey results from The Ohio State University."While I'm not surprised about this result, I am deeply concerned because we know that the more of us who are prepared to save a life, the more lives we can s |
HealthDay
26 August at 02.26 PM
Vaccination Coverage for Teens Similar in 2023 and 2022In 2023, vaccination coverage for adolescents with all routine vaccines was similar to coverage in 2022, according to research published in the Aug. 22 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues analyzed data from t |
HealthDay
26 August at 02.01 PM
Olaparib Monotherapy Yields Good PSA Response Rates in Prostate CancerFor men with high-risk biochemically recurrent prostate cancer, olaparib monotherapy yields good prostate-specific antigen (PSA) response rates, especially among those with BRCA2, according to a study published online Aug. 22 in JAMA Oncology.Catherine H. Marshall, M.D., from the Johns Hopkins University School of Medicine in B |
HealthDay
26 August at 10.50 AM
U.S. Will Offer Free COVID Tests By Mail by Late SeptemberAs a summer surge in COVID cases begins to ebb and Americans brace themselves for yet another wave of infections this winter, more free COVID tests will soon be available to all, federal health officials announced Friday.Starting in late September, every U.S. household can order up to four nasal swab tests when the federal program reopens, accor |
HealthDay
23 August at 10.39 PM
Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in Diabetes, Obesity and Metabolism.Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence amo |
HealthDay
23 August at 03.44 PM
Socially, Economically Disadvantaged Communities Lack Access to BuprenorphineRestricted buprenorphine dispensing was most pronounced in socially and economically disadvantaged communities, according to a study published in the September issue of Drug and Alcohol Dependence Reports.Kyle J. Moon, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a U.S. telephone a |
HealthDay
23 August at 03.16 PM
Belzutifan Improves Progression-Free Survival in Advanced Renal Cell CancerBelzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study published in the Aug. 22 issue of the New England Journal of Medicine.Toni K. Choueiri, M.D., from the Dana-Farber Can |
HealthDay
22 August at 06.40 PM
FDA Approves Updated COVID Shots for FallUpdated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.This year's approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 1 |
HealthDay
21 August at 03.20 PM
Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality AnalysisSemaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse drug re |
HealthDay
20 August at 08.49 PM
This Week Could Bring FDA Approval of Fall COVID-19 VaccinesUpdated COVID-19 vaccines may receive approval from the U.S. Food and Drug Administration this week.Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target the KP.2 variant could be greenlit as early as this week. The news agency said the sources declined to be named because informati |
HealthDay
16 August at 09.19 PM
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerFor patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research published online July 10 in the Journal of Hepatology.Mohammad Saeid Rezaee-Zavareh, from the Middle East Liver Diseases Center in Tehran, Iran, and colleagues summarized |
HealthDay
16 August at 03.11 PM
Maternal Epilepsy Tied to Increased Maternal Morbidity, Perinatal Mortality and MorbidityWomen with epilepsy have a considerably higher risk for severe maternal and perinatal outcomes and an increased risk for death during pregnancy and postpartum, according to a study published online Aug. 5 in JAMA Neurology.Neda Razaz, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined associations between m |
HealthDay
15 August at 10.00 PM
FDA Approves Nemluvio for Prurigo NodularisThe U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi |
HealthDay
15 August at 03.16 PM
ADHD Medications Also Improve Quality of LifeMedications for attention-deficit/hyperactivity disorder (ADHD) are effective at improving quality of life in people with the disorder, according to a review recently published in the Journal of the American Academy of Child & Adolescent Psychiatry.Alessio Bellato, Ph.D., from the University of Southampton in the United Kingd |
HealthDay
15 August at 03.13 PM
Problematic Pharmaceutical Opioid Use Common in Noncancer PainFor individuals with chronic noncancer pain (CNCP) treated with opioid analgesics, problematic pharmaceutical opioid use (POU) is common, according to a study published online Aug. 7 in Addiction.Kyla H. Thomas, Ph.D., M.B.B.S., from the University of Bristol in the United Kingdom, and colleagues conducted a comprehensive systematic l |
HealthDay
15 August at 11.36 AM
New Deals Will Cut Medicare Costs for Expensive DrugsThe Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.Taxpayers should save $6 billion because of the new prices, while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for |
HealthDay
14 August at 10.28 PM
Vaccines for Children Program Has Increased Coverage, but Gaps RemainThe Vaccines for Children (VFC) program, which provides recommended vaccines at no cost to eligible children, has increased childhood vaccination coverage, but coverage is still lower than among non-VFC-eligible children, according to a Vital Signs report published Aug. 13 in the U.S. Centers for Disease Control and Prevention Morbidity |
HealthDay
14 August at 10.22 PM
Most Patients With MS Have No Risk for Relapse After COVID-19 VaccinationFor most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in Neurology.Xavier Moisset, M.D., Ph.D., from the Universite Clermont Auvergne in Clermont-Ferrand, France, and colleagues conducted a nationwide study using data from the F |
HealthDay
14 August at 03.53 PM
Past-Month Cannabis Use Increasing Among Adults With DiabetesAmong U.S. adults with diabetes, cannabis use in the past month increased by 33.7 percent from 2021 to 2022, according to a research letter published online July 22 in Diabetes Care.Benjamin H. Han, M.D., M.P.H., from the University of California, San Diego, School of Medicine in La Jolla, and colleagues estimated the most recent nat |
HealthDay
14 August at 03.43 PM
Fish Oil Supplements Counteract Genetic Predisposition to High CholesterolFish oil seems to counteract genetic predisposition to high cholesterol, according to a study published online July 15 in the American Journal of Clinical Nutrition.Yitang Sun, Ph.D., from the Franklin College of Arts and Sciences at the University of Georgia in Athens, and colleagues examined whether fish oil supplementation mo |
HealthDay
14 August at 03.37 PM
Sacituzumab Govitecan Shows Promise in Advanced Endometrial CancerFor patients with advanced endometrial cancer (EC), sacituzumab govitecan (SG), a trophoblast cell-surface antigen 2 (Trop-2)-directed antibody-drug conjugate, shows encouraging efficacy, according to a phase 2 study published online July 31 in the Journal of Clinical Oncology.Alessandro D. Santin, M.D., from the Yale School of Medic |
HealthDay
12 August at 09.50 PM
GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 DiabetesTreatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor (RASi) discontinuation compared with treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) among patients with type 2 diabetes (T2D), according to a study published online Aug. 1 |
HealthDay
12 August at 09.46 PM
Buprenorphine + Naloxone Safe for Opioid Addiction in PregnancyPregnancies exposed to buprenorphine combined with naloxone have similar or more favorable neonatal and maternal outcomes as those exposed to buprenorphine alone, according to a study published online Aug. 12 in the Journal of the American Medical Association.Loreen Straub, M.D., from Brigham and Women's Hospital and Harvard Medical Sch |
HealthDay
12 August at 04.11 PM
Risks for Mortality, Adverse Heart, Kidney Events Lower With Tirzepatide for T2DMFor patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney events compared with glucagon-like peptide 1 receptor agonist treatment (GLP-1 RA), according to a s |
HealthDay
12 August at 03.54 PM
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With EczemaFor patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini |
HealthDay
12 August at 03.47 PM
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma PatientsA gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in |
HealthDay
12 August at 03.44 PM
Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug ReactionsSulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w |
HealthDay
12 August at 10.57 AM
FDA Says No to MDMA as Therapy for PTSDAdvocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a setback on Friday after the U.S. Food and Drug Administration declined to approve it as treatment for post-traumatic stress disorder (PTSD).There is insufficient evidence that MDMA -- currently illegal and also known as Ecstasy |
HealthDay
09 August at 03.40 PM
FDA Approves Voranigo for Grade 2 Astrocytoma or OligodendrogliomaThe U.S. Food and Drug Administration has approved Voranigo (vorasidenib) for grade 2 astrocytoma or oligodendroglioma with a susceptible mutation.The isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor is approved for adult and pediatric patients ages 12 years and older with grade 2 astrocytoma or oligodendroglioma |
HealthDay
09 August at 03.34 PM
Childhood Vaccinations Have Prevented ~508 Million Lifetime Cases of IllnessChildhood vaccinations continue to provide substantial health and economic benefits, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Noting that the U.S. Vaccines for Children (VFC) program has covered the cost of vaccines for children whose |
HealthDay
09 August at 03.30 PM
CDC Updates Practice Recommendations for ContraceptivesIn two practice recommendations published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, updated recommendations are presented relating to use of specific contraceptive methods and for persons with certain characteristics or medical conditions.Kathryn M. Curtis, Ph.D., fr |
HealthDay
08 August at 04.04 PM
Long-Acting Cabotegravir Well Tolerated in Pregnant WomenLong-acting injectable cabotegravir (CAB-LA) appears to be well tolerated in pregnant women, according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Sinead Delany-Moretlwe, M.B.B.Ch., Ph.D., from the University of the Witwatersrand in South Africa, and colleagues reported on materna |
HealthDay
08 August at 04.00 PM
Abacavir Use Linked to Increased Incidence of MACEFor patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was associated with an increased incidence of major adverse cardiovascular events (MACE), according to a study presented at AIDS 2024, the 25th International AIDS Conference, held from July 22 to 26 in Munich.Carl J. Fichtenbaum, M. |
HealthDay
08 August at 03.48 PM
Interprofessional Addiction Consultation Ups Medication for Opioid Use DisorderInterprofessional addiction consultation services significantly increase postdischarge medication for opioid use disorder (MOUD) initiation and engagement among patients with opioid use disorder, according to a study published online July 29 in JAMA Internal Medicine.Jennifer McNeely, M.D., from New York University Grossman School |
HealthDay
07 August at 11.01 PM
Nipocalimab Can Delay, Prevent Anemia, Intrauterine TransfusionFor pregnancies at high risk for early-onset severe hemolytic disease of the fetus and newborn (HDFN), intravenous nipocalimab can delay or prevent fetal anemia or intrauterine transfusions, according to a study published online Aug. 7 in the New England Journal of Medicine.Kenneth J. Moise Jr., M.D., from Dell Medical School at the U |
HealthDay
07 August at 10.55 PM
FDA Approves Darzalex Faspro for Treating Multiple MyelomaThe U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for induction and consolidation in patients with newly diagnosed multiple myeloma (MM) who are eligible for an autologous stem cell transplant (ASCT).The approval was ba |
HealthDay
07 August at 03.26 PM
Pharmacogenomic Score Can Personalize Treatment of Leukemia in ChildrenFor pediatric patients with acute myeloid leukemia (AML), a pharmacogenomics-based 10 single nucleotide polymorphism cytarabine (Ara-C) score (ACS10) can be used to tailor induction regimens, yielding improved outcomes, according to a study published online July 30 in Clinical Cancer Research.Noting that low ACS10 has been shown to be |
HealthDay
06 August at 11.08 PM
Many U.S. Adults Lost Trust in Physicians, Hospitals During PandemicU.S. adults lost trust in physicians and hospitals during the COVID-19 pandemic, according to a study published online July 31 in JAMA Network Open.Roy H. Perlis, M.D., from Massachusetts General Hospital in Boston, and colleagues examined how trust in physicians and hospitals changed during the COVID-19 pandemic. The analysis incl |
HealthDay
06 August at 11.01 PM
FDA Approves Tecelra as First Gene Therapy for Synovial SarcomaThe U.S. Food and Drug Administration has approved Tecelra (afamitresgene autoleucel), a gene therapy for the treatment of adults with unresectable or metastatic synovial sarcoma.Specifically, the approval is for adults who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and have a tumor that expr |
HealthDay
06 August at 03.47 PM
Aspirin-Linked Reduction in CRC Risk Varies With Lifestyle ScoreAspirin use is associated with a reduction in colorectal cancer (CRC) risk, with the greatest reduction seen among those with the unhealthiest lifestyle scores, according to a study published online Aug. 1 in JAMA Oncology.Daniel R. Sikavi, M.D., from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues ex |
HealthDay
05 August at 04.10 PM
Potentially Hepatotoxic Botanicals Frequently Used in United StatesAn estimated 15 million U.S. adults consumed at least one of six potentially hepatotoxic botanicals within the previous 30 days, according to a study published online Aug. 5 in JAMA Network Open.Alisa Likhitsup, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues assessed the prevalence and clinical characteristics |
HealthDay
05 August at 04.03 PM
2021 to 2023 Saw Considerable Increase in Semaglutide FillsFrom 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum.Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, and colleagues analyzed trends in prescriptions dispensed at retail pharmac |
HealthDay
05 August at 03.44 PM
Monitoring Important With Antidepressants for Alcohol Use DisorderFor patients with alcohol use disorder (AUD) treated with antidepressants, those who achieve a reduction in depression symptoms have fewer relapses over time, according to a study published online July 26 in Alcohol: Clinical & Experimental Research.Joshua Jaeger, from the University of Bern in Switzerland, and colleagues examined th |
HealthDay
05 August at 03.37 PM
Oversight of DOAC Prescribing Beneficial for A-Fib, VTE PatientsDirect oral anticoagulant (DOAC) prescribing oversight for off-label prescribing is beneficial while patients are prescribed DOAC, according to a study published online July 30 in Thrombosis and Haemostasis.Grace C. Herron, from the Frankel Cardiovascular Center at the University of Michigan in Ann Arbor, and colleagues evaluated data fr |
HealthDay
02 August at 11.01 PM
Availability Increased With Approval of Naloxone as OTC MedicationRecently, there was an increase in availability of naloxone after it was approved to be sold as an over-the-counter (OTC) medication, according to a study published online July 26 in JAMA Health Forum.Grace T. Marley, Pharm.D., from the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina, and colleagues examined whether the ac |
HealthDay
02 August at 10.52 PM
FDA Approves Leqselvi for Severe AlopeciaThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was |
HealthDay
02 August at 04.03 PM
Semaglutide Products Being Sold Online Without PrescriptionsSemaglutide products are being sold online, with products likely unregistered or unlicensed, according to a research letter published online Aug. 2 in JAMA Network Open.Amir Reza Ashraf, Pharm.D., from the University of Pécs in Hungary, and colleagues conducted a risk assessment of semaglutide online sourcing. Websites advertising semagl |
HealthDay
01 August at 04.02 PM
Pharmacist Prescribing Can Reduce Stroke Risk in A-Fib PatientsCommunity pharmacists can play an effective role in closing gaps in the delivery of stroke risk reduction therapy by prescribing appropriate oral anticoagulation therapy (OAC) for high-risk older individuals with atrial fibrillation (AF), according to a study published online July 24 in JAMA Network Open.Roopinder K. Sandhu, M.D. |
HealthDay
01 August at 03.47 PM
COVID-19 Vaccination May Increase Risk for Urinary Tract SymptomsCOVID-19 vaccination seems to have some side effects on the lower urinary tract and overactive bladder in younger adults, according to a study published online June 24 in Frontiers in Medicine.Marta de-la-Plaza-San-Frutos, from Universidad Europea de Madrid in Spain, and colleagues examined potential side effects of COVID-19 vaccinatio |
HealthDay
31 July at 03.53 PM
Cholesterol Absorption Inhibitors May Cut Risk for Liver CancerThe use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in Cancer.Shahriar A. Zamani, Ph.D., from the National Cancer Institute at the National Institutes of Health in Rockville, Maryland, and colleagues examined the risk for liver cancer for |
HealthDay
31 July at 03.35 PM
Methotrexate Beneficial for Reducing Pain, Stiffness in Knee OsteoarthritisFor patients with knee osteoarthritis (KOA), methotrexate added to usual medication is associated with a significant reduction in pain and improvement in stiffness and function at six months, according to a study published online July 30 in the Annals of Internal Medicine.Sarah R. Kingsbury, Ph.D., from the University of Leeds in the |
HealthDay
30 July at 03.43 PM
Toxicities Rare After Two Weeks of CAR T-Cell Therapy InfusionNew-onset cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are rare beyond two weeks following infusion of CD19-directed chimeric antigen receptor T (CAR T)-cell therapies, according to a study published online July 23 in Blood Advances.Noting that the U.S. Food and Drug Administration |
HealthDay
30 July at 03.37 PM
Study Looks at Opioid Dispensing Among Youths Undergoing SurgeryOverall, 16.2 percent of opioid-naive youths undergoing a surgical procedure filled an initial opioid prescription one to 14 days before surgery, according to a study published online July 5 in JAMA Network Open.Tori N. Sutherland, M.D., M.P.H., from the Children's Hospital of Philadelphia, and colleagues characterized changes in preop |
HealthDay
30 July at 03.32 PM
Nasal Sprays, Behavioral Intervention Aid in Treatment of Respiratory IllnessUse of nasal sprays and a behavioral intervention promoting physical activity and stress management can reduce antibiotic use for respiratory illness, according to a study published online July 11 in The Lancet Respiratory Medicine.Paul Little, M.B.B.S., M.D., from the University of Southampton in the United Kingdom, and colleagues exa |
HealthDay
30 July at 03.26 PM
Once-Daily TAS-303 Superior to Placebo for Stress Urinary IncontinenceOnce-daily TAS-303 is superior to placebo for treatment of stress urinary incontinence (SUI) in women, according to a study published in the August issue of The Journal of Urology.Satoru Takahashi, M.D., Ph.D., from Nihon University School of Medicine in Tokyo, and colleagues conducted a double-blind phase 2 study involving women with |
HealthDay
30 July at 09.57 AM
FDA Warns of Accidental Overdoses From Compounded Versions of OzempicPeople taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns.These ODs typically are due to miscommunications or miscalculations regarding dosage, the FDA added.“Dosing errors have res |
HealthDay
29 July at 09.30 PM
Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use DisorderFor patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures compared with other antidiabetes medications, according to a study published online July 30 in the Annals of Internal Medicine.William Wang, from the Case Western Rese |
HealthDay
29 July at 03.30 PM
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable CabotegravirIn a research letter published online July 24 in the New England Journal of Medicine, the authors describe long-acting early viral inhibition (LEVI) among patients with acute HIV infection in the context of long-acting injectable cabotegravir (CAB-LA) preexposure prophylaxis (PrEP). The research was published to coincide with the 25th Internat |
HealthDay
29 July at 03.30 PM
Blinatumomab + Chemo Ups Survival in B-Cell Precursor Acute Lymphoblastic LeukemiaFor adult patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who have measurable residual disease (MRD)-negative remission, blinatumomab in addition to consolidation chemotherapy is associated with improved overall survival, according to a study published in the July 25 issue of the New England Journal of Medicine.Mar |
HealthDay
26 July at 03.50 PM
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen SclerosusHydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog |
HealthDay
26 July at 10.45 AM
Certain Abbott Blood Sugar Monitors May Give Incorrect ReadingsAbbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3 sensors that may provide incorrect high glucose readings, which if undetected may pose a potential health risk for people living |
HealthDay
26 July at 10.12 AM
Fake Oxycontin Pills Widespread and Potentially Deadly: ReportThe rate at which young Americans are ending up in hospital ICUs after using fake Oxycontin pills spiked with fentanyl is soaring, especially in the U.S. West, a new report warns.Medical toxicology data from one unnamed hospital in the western U.S. found the number of cases involving overdoses involving fake "M-30" Oxycontin pills rose from just |
HealthDay
25 July at 06.45 PM
Declines Seen in Medical, Nonmedical Use of Prescription Meds Among TeensU.S adolescents reported declines in medical use and nonmedical use (NMU) of prescription stimulants, opioids, and benzodiazepines from 2009 to 2022, according to a research letter published online July 24 in the Journal of the American Medical Association.Sean Esteban McCabe, Ph.D., from the University of Michigan School of Nursing i |
HealthDay
25 July at 03.23 PM
Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle CellFor girls and young women with sickle cell disease (SCD), exposure to hydroxyurea does not reduce ovarian reserve, according to a study published online July 18 in Blood Advances.Tamara Diesch-Furlanetto, Ph.D., from the University of Basel Children's Hospital in Switzerland, and colleagues counted follicles and categorized them based |
HealthDay
24 July at 03.24 PM
Lack of Institutional Support May Drive Physician Reluctance to Address AddictionLack of institutional support is the most common reason for physicians to have reluctance to address substance use and addiction in their clinical practices, according to a review published online July 17 in JAMA Network Open.Melinda Campopiano von Klimo, M.D., from JBS International Inc. in North Bethesda, Maryland, and colleag |
HealthDay
24 July at 03.23 PM
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for EczemaUse of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee |
HealthDay
23 July at 10.27 PM
Long-Term Sulfonylurea Use Tied to Impaired Awareness of HypoglycemiaThe prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the Annals of Family Medicine.Hsiang-Ju Cheng, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues investigated the relationship bet |
HealthDay
23 July at 03.50 PM
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-FibFor patients with atrial fibrillation, digoxin and beta-blockers have equivalent effects on heart rate at rest and on exertion, according to a study published online July 15 in Nature Medicine.Simrat K. Gill, from the University of Birmingham in the United Kingdom, and colleagues compared heart rate in older, multimorbid patients with |
HealthDay
23 July at 03.45 PM
Long COVID Incidence Declined Over Course of PandemicThe cumulative incidence of postacute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection (PASC) during the first year after infection decreased over the course of the pandemic, according to a study published online July 17 in the New England Journal of Medicine.Yan Xie, Ph.D., from the Veterans Affa |
HealthDay
22 July at 09.49 PM
2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist PrescriptionsFrom 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a research letter published online July 23 in the Annals of Internal Medicine.Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined nationwide trends in GLP-1RA prescription |
HealthDay
22 July at 09.48 PM
Study Looks at Co-Use of CYP2D6-Metabolizing Opioids, Antidepressants in SeniorsFor older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adverse events (ORAEs), according to a study published online July 23 in the Annals of Internal Medicine.Yu-Jung Jenny Wei, Ph.D., from the C |
HealthDay
22 July at 03.15 PM
Neuromuscular Training Cuts Onset of Chemo-Induced Peripheral NeuropathyNeuromuscular training reduces the onset of chemotherapy-induced peripheral neuropathy (CIPN), according to a study published online July 1 in JAMA Internal Medicine.Fiona Streckmann, Ph.D., from the University of Basel in Switzerland, and colleagues examined whether sensorimotor training (SMT) and whole-body vibration (WBV) training re |
HealthDay
19 July at 04.13 PM
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia AFor children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa is associated with high sustained factor VIII activity, resulting in effective prevention of bleeding, according to a study published in the July 18 issue of the New England Journal of Medicine.Lynn Malec, M.D., from the Versiti Blood Research Institu |
HealthDay
19 July at 03.54 PM
Micronutrient Supplementation Slows Geographic Atrophy ProgressionOral micronutrient supplementation slows geographic atrophy (GA) progression in age-related macular degeneration (AMD), according to a study published online July 16 in Ophthalmology.Tiarnan D.L. Keenan, B.M., B.Ch., Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined whether oral supplements slo |
HealthDay
19 July at 03.51 PM
COVID-19 Infection, Vaccination Not Linked to Congenital AnomaliesCOVID-19 infection and vaccination during the first trimester of pregnancy are not associated with congenital anomalies, according to a study published online July 17 in The BMJ.Maria C. Magnus, Ph.D., from the Norwegian Institute of Public Health in Oslo, and colleagues conducted a prospective cohort study of 343,066 live-born singleto |
HealthDay
18 July at 04.04 PM
Postexposure Prophylaxis With Nirmatrelvir-Ritonavir Does Not Cut COVID-19 InfectionPostexposure prophylaxis with nirmatrelvir-ritonavir for five or 10 days does not reduce the risk for symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published in the July 18 issue of the New England Journal of Medicine.Jennifer Hammond, Ph.D., from Pfizer in Collegeville, Penns |
HealthDay
17 July at 10.29 PM
Risankizumab Noninferior, Superior to Ustekinumab for Crohn DiseaseFor patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the July 18 issue of the New England Journal of Medicine.Laurent Peyrin-Biroulet, M.D., Ph.D., from the INFINY Institut |
HealthDay
17 July at 10.27 PM
Ofatumumab Effective for MS Across Racial, Ethnic SubgroupsFor patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study published online July 17 in Neurology.Mitzi J. Williams, M.D., from the Joi Life Wellness MS Center in Atlanta, and colleagues conducted a post-hoc analysis to compare the prop |
HealthDay
17 July at 03.29 PM
Extended-Release Oral Ketamine Effective for Treatment-Resistant DepressionFor patients with treatment-resistant depression, racemic ketamine, given as an extended-release tablet (R-107), administered orally, is effective, safe, and well tolerated, according to a study published online June 24 in Nature Medicine.Paul Glue, M.D., from the University of Otago in Dunedin, New Zealand, and colleagues examined t |
HealthDay
17 July at 03.14 PM
Aging Into Medicare Tied to Higher Drug Costs for People With DiabetesAs people with diabetes age into Medicare, they face increased quarterly out-of-pocket costs for medication, according to a study published online July 9 in JAMA Network Open.Douglas Barthold, Ph.D., from the University of Washington in Seattle, and colleagues examined whether reaching age 65 years is associated with changes in |
HealthDay
16 July at 10.52 PM
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With MigraineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris |
HealthDay
16 July at 03.47 PM
Benzodiazepines Not Tied to Higher Dementia Risk in Older AdultsUse of benzodiazepines is not associated with increased dementia risk in older adults, according to a study published online July 2 in BMC Medicine.Ilse vom Hofe, from Erasmus University Medical Center in the Netherlands, and colleagues examined long-term effects of benzodiazepines (anxiolytics or sedative-hypnotics) on neurodegen |
HealthDay
16 July at 03.40 PM
Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop WasteSelf-imposed use cessation dates (SUCD) for multiuse eye drop bottles leads to significant drug waste and associated costs, according to a report published online July 1 in Ophthalmology.John M. Tan, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues quantified the volume of drugs discarded in ambula |
HealthDay
16 July at 03.29 PM
Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2DFor older adults with type 2 diabetes (T2D), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is not associated with a significantly increased risk for suicidal ideation and behaviors, according to a study published online July 16 in the Annals of Internal Medicine.Huilin Tang, from the University of Florida College of Phar |
HealthDay
15 July at 10.00 PM
Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia RiskCompared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk, according to a review published online May 3 in the American Journal of Preventive Medicine.Yongjun Sunwoo, from the College of Pharmacy at Kyung Hee University in Seoul, South Korea, an |
HealthDay
15 July at 03.23 PM
Low Quantity of Opioids Used After ED Discharge for Acute PainFor patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published online July 15 in CMAJ, the journal of the Canadian Medical Association.Raoul Daoust, M.D., from Sacré-Coeur Hospital in Montreal, and co |
HealthDay
15 July at 12.36 PM
Global Childhood Vaccination Rates Still Haven't Recovered from Pandemic DeclinesMore than four years after the pandemic began, childhood vaccination rates worldwide have yet to recover, a new report shows.The latest data, issued Monday by the World Health Organization and the United Nations International Children’s Emergency Fund (UNICEF), underscore the need for continuing to try to catch-up to pre-pandemic levels.“ |
HealthDay
12 July at 10.23 PM
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox InjectionsSeven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact |
HealthDay
12 July at 10.21 PM
More Women Than Men Experience Nonphysical Violence in Health Care WorkforceWomen in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin |
HealthDay
12 July at 10.16 PM
Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years LaterThree of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss, according to new analysis conducted by Prime Therapeutics and Magellan Rx Management (MRx).For the review, pharmacy and medical claims data for 3,364 people with insurance pl |
HealthDay
12 July at 03.43 PM
More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use DisorderMany people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28 in JAMA Network Open.Brandon del Pozo, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues surveyed 1,234 individu |
HealthDay
12 July at 03.38 PM
Prenatal Vaccination With RSV Prefusion F Does Not Increase Risk for Preterm BirthPrenatal vaccination with a nonadjuvanted bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) protein subunit vaccine is not associated with an increased risk for preterm birth (PTB), according to a study published online July 8 in JAMA Network Open.In a retrospective observational cohort study, Moeun Son, M.D., from the We |
HealthDay
11 July at 10.11 PM
FDA Approves Zoryve for Atopic DermatitisThe U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu |
HealthDay
11 July at 04.04 PM
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2DFor patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine |
HealthDay
11 July at 03.45 PM
First-Trimester COVID-19 Vaccine Does Not Increase Risk for Birth DefectsFirst-trimester mRNA COVID-19 vaccine exposure is not associated with an increased risk for selected major structural birth defects, according to a study published online July 1 in JAMA Pediatrics.Elyse O. Kharbanda, M.D., M.P.H., from HealthPartners Institute in Minneapolis, and colleagues assessed whether receipt of an mRNA COV |
HealthDay
10 July at 10.23 PM
Nirsevimab Effective Against RSV-Linked Bronchiolitis HospitalizationNirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a study published in the July 11 issue of the New England Journal of Medicine.Zein Assad, M.D., from the Robert Debré University Hospital in Paris, and colleagues conduct |
HealthDay
10 July at 03.58 PM
Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual CareIncentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according to a study published online July 2 in JAMA Network Open.Darla E. Kendzor, Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues randomly assign |
HealthDay
10 July at 03.12 PM
Most Children With Conjunctivitis Have Rx for Topical Antibiotics FilledMore than two-thirds of children with conjunctivitis have a prescription filled for topical antibiotics within one day of an ambulatory care visit, according to a research letter published online June 27 in JAMA Ophthalmology.Daniel J. Shapiro, M.D., M.P.H., from the University of California, San Francisco, and colleagues examined pr |
HealthDay
09 July at 03.32 PM
1999 to Mid-2000s Saw Increase in Seniors Using Prescription MedsFrom 1999 to the mid-2000s, the proportion of U.S. adults aged 65 years or older who used prescription medications increased, according to a research letter published online July 1 in JAMA Internal Medicine.Gabriel K. Innes, V.M.D., Ph.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues analyzed dat |
HealthDay
09 July at 12.41 PM
More Americans Now Think Abortion Should Be Allowed in Any CircumstanceTwo years after the U.S. Supreme Court overturned Roe v. Wade, more Americans think their state should allow a woman to get a legal abortion for any reason, a new poll finds.Just over 6 in 10 of those questioned say women should have that right, compared to just under 50% of Americans who held the same belief in 2021, the new <a href="https://ap |
HealthDay
08 July at 09.38 PM
Significantly More Weight Loss Seen With Tirzepatide Versus SemaglutideTirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointest |
HealthDay
08 July at 09.36 PM
Acupuncture Can Reduce Methadone Dose, Opioid CravingFor individuals with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone dose and opioid craving, according to a study published online July 9 in the Annals of Internal Medicine.Liming Lu, M.D., from the Guangzhou University of Chinese Medi |
HealthDay
08 July at 09.33 PM
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-FibFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study published online July 9 in the Annals of Internal Medicine.Tracey G. Simon, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and co |
HealthDay
08 July at 03.26 PM
Tisotumab Vedotin Efficacious for Recurrent Cervical CancerSecond- or third-line treatment with tisotumab vedotin is efficacious for patients with recurrent cervical cancer, according to a study published in the July 4 issue of the New England Journal of Medicine.Ignace Vergote, M.D., Ph.D., from Universitaire Ziekenhuizen Leuven in Belgium, and colleagues conducted a phase 3, multinational, ope |
HealthDay
08 July at 03.17 PM
ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement TherapyFor individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment is associated with a reduced risk for kidney failure with replacement therapy (KFRT) but not death, according to a study published online July 2 in the Annals of Internal Medicine.Elai |
HealthDay
08 July at 02.56 PM
Study Looks at Abortion Rates With No-Test Telehealth Screening, Meds MailingAccess to medication abortion using history-based (no-test) eligibility assessment, including through telehealth, and mailing of mifepristone lead to similar rates of complete abortion as in-person care with ultrasonography, according to a study published online June 24 in the Journal of the American Medical Association.Lauren J. Ralph, |
HealthDay
08 July at 02.52 PM
Granting Waiver for Cancer Treatment Does Not Affect Safety, Efficacy OutcomesIn a trial involving patients with therapy-refractory cancer treated with approved targeted or immunotherapies, matched to their tumor molecular profile but outside their registered indications, those for whom a waiver was granted had similar serious adverse event rates and clinical benefit rates as those who did not receive a waiver, according to a stu |
HealthDay
03 July at 08.32 PM
Semaglutide Linked to Nonarteritic Anterior Ischemic Optic NeuropathySemaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and |
HealthDay
03 July at 03.07 PM
Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma SymptomsHigher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter published online July 3 in JAMA Network Open.Matthew M. Davis, M.D., from Nemours Children's Health in Wilmington, Delaware, and Lakshmi K. Halasyamani, M.D., from Endeavor Health in Eva |
HealthDay
03 July at 02.50 PM
Many Teen Girls Seeking Care in the ED at High Risk for PregnancySexually active adolescents seeking care in the emergency department have a high risk for pregnancy, and the emergency department may provide a feasible environment to offer contraception counseling, according to a study published online June 28 in JAMA Network Open.Hannah Canter, M.D., from Oregon Health and Science University i |
HealthDay
02 July at 07.33 PM
FDA Approves New Drug to Treat Alzheimer'sA new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday.In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the m |
HealthDay
02 July at 05.05 PM
U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu VaccineU.S. health officials announced Tuesday that the federal government will pay Moderna $176 million to speed development of a pandemic flu vaccine based on mRNA technology.Such a vaccine could be used to treat bird flu in people, as concern grows about H5N1 cases spreading in dairy cows across the country, the U.S. Department of Health a |
HealthDay
02 July at 04.01 PM
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 MillionThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass |
HealthDay
01 July at 10.10 PM
Small Differences in Weight Change With First-Line AntidepressantsFor eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study published online July 2 in the Annals of Internal Medicine.Joshua Petimar, Sc.D., from Harvard Medical School and Harvard Pilgrim Health Care Institute in Boston, and colleagues conducted |
HealthDay
01 July at 03.22 PM
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung CancerFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line treatment, according to a study published online June 26 in the New England Journal of Medicine.Byoung C. Cho, M.D., Ph.D., from the Yonsei Cancer Ce |
HealthDay
28 June at 10.09 PM
NCCN: Cancer Drug Shortages Remain a Challenge for CliniciansAlmost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National Comprehensive Cancer Network survey.Following data published one year ago and six months ago illustrating shortages of crucial cancer drugs, the National Comprehensive Cancer Network published new results |
HealthDay
28 June at 09.54 PM
Small Number of Procedures Account for Large Number of Opioid PrescriptionsA small number of surgical procedures, including orthopedic procedures and cesarean delivery, account for a large proportion of opioid prescriptions dispensed after surgery, according to a study published online June 26 in JAMA Network Open.Dominic Alessio-Bilowus, from Michigan Medicine in Ann Arbor, and colleagues examined the surgica |
HealthDay
28 June at 03.02 PM
Clinical Response Seen for Patients With Severe Asthma Initiating BiologicsPatients with severe asthma initiating biologics exhibit clinical responses and super-responses, but 40 to 50 percent do not meet response criteria, according to a study published online June 22 in Allergy.Eve Denton, M.B.B.S., from Alfred Health in Melbourne, Australia, and colleagues examined responsiveness to biologics in a real-worl |
HealthDay
28 June at 03.01 PM
Guidelines Address RT for Management of HPV-Linked Oropharyngeal CancerIn a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT) for management of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC).Danielle N. Margali |
HealthDay
28 June at 02.12 PM
Supreme Court Rejects Purdue Pharma Opioid SettlementThe U.S. Supreme Court on Thursday struck down a controversial settlement that drug maker Purdue Pharma had reached with victims of the opioid epidemic.The ruling threatens a massive bankruptcy plan that would have protected the Sackler family, which controls the compan |
HealthDay
28 June at 11.51 AM
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of AgeAs a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans over the age of 6 months get one of the updated COVID vaccines when they become available this fall.The recommendation was issued Thurs |
HealthDay
27 June at 09.36 PM
Only One-Quarter of Adults Who Needed Opioid Use Disorder Meds in 2022 Received ThemOnly one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according to research published in the June 27 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Deborah Dowell, M.D., from the CDC in Atlanta, and colleagues characterized U. |
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
HealthDay
27 June at 03.18 PM
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMDFor adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health, according to a study published online June 25 in JAMA Network Open.Simon Birk Kjær Jensen, Ph.D., from the University of Copenhagen in Denm |
HealthDay
27 June at 03.16 PM
ADA: Inhaled Insulin Shows Promise for Adults With Type 1 DiabetesInhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Irl B. Hirsch, M.D., from the University of Washington in S |
HealthDay
27 June at 03.14 PM
Dupilumab Ups Histologic Response for Pediatric Eosinophilic EsophagitisFor children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission, according to a study published in the June 27 issue of the New England Journal of Medicine.Mirna Chehade, M.D., M.P.H., from Icahn School of Medicine at Mount Sinai in New York City, and colleagues randomly assig |
HealthDay
27 June at 03.13 PM
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon CancerPIK3CA mutational status may be beneficial for predicting response to addition of the cyclooxygenase 2 (COX-2) inhibitor celecoxib to standard adjuvant chemotherapy in stage III resected colon cancer, according to a study published online June 18 in the Journal of Clinical Oncology.Jonathan A. Nowak, M.D., Ph.D., from Brigham |
HealthDay
27 June at 11.32 AM
CDC Strengthens RSV Vaccine Advice for Those Over 75In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives.However, those a bit younger -- ages 60 to 74 -- should only seek the shot if they are vulnerable to severe RSV because of chronic medical conditions such as lung or heart disease, or if |
HealthDay
26 June at 09.35 PM
Atogepant Efficacious for Patients With Chronic MigraineFor patients with chronic migraine (CM), with and without medication overuse, atogepant is efficacious, according to a study published online June 27 in Neurology.Peter J. Goadsby, M.D., Ph.D., from King's College London, and colleagues examined the efficacy of atogepant for the preventive treatment of CM in participants with and wit |
HealthDay
26 June at 09.32 PM
Histologic Response Up With Benralizumab for Eosinophilic EsophagitisBenralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not affect dysphagia symptoms, according to a study published in the June 27 issue of the New England Journal of Medicine.Marc E. Rothenberg, M.D., Ph.D., from the Leiden University Medical Center in the Netherlands, an |
HealthDay
26 June at 07.46 PM
Multivitamin Use Not Linked to Mortality Benefit in U.S. AdultsMultivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network Open.Erikka Loftfield, Ph.D., M.P.H., from the National Institutes of Health in Rockville, Maryland, and colleagues estimated the association of MV use with mortality risk, accounting for con |
HealthDay
26 June at 06.03 PM
Glofitamab + GemOx Superior to Rituximab + GemOx for LymphomaGlofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) is superior to rituximab (R)-GemOx for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), according to a study presented at the annual hybrid congress of the European Hematology Association, held from June 13 to 16 in Madrid.Jeremy Abramson, M.D., from the Massachusett |
HealthDay
26 June at 04.53 PM
Decrease in Oral Contraceptive Fills Seen After Dobbs RulingThe Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines in prescription fills for oral contraceptives, according to a study published online June 26 in JAMA Network Open.Dima M. Qato, Pharm.D., M.P.H., Ph.D., from the University of |
HealthDay
26 June at 04.05 PM
Pediatric Surgical Opioid Prescribing Concentrated Among a Few ProceduresPediatric surgical opioid prescribing is concentrated among a small number of procedures, especially tonsillectomy and/or adenectomy, according to a study published online June 26 in Pediatrics.Kao-Ping Chua, M.D., Ph.D., from the Institute for Healthcare Policy and Innovation in Ann Arbor, Michigan, and colleagues conducted a cross- |
HealthDay
26 June at 03.26 PM
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart FailureFor patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar improvements in heart failure-related symptoms in men and women, according to a study published online June 23 in the Journal of the American College of Cardiology to coinc |
HealthDay
26 June at 03.26 PM
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSATirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At |
HealthDay
25 June at 09.42 PM
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusFor patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine |
HealthDay
25 June at 03.06 PM
COVID-19 Vaccination Not Tied to Adverse Pregnancy OutcomesmRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the June issue of Obstetrics & Gynecology.Kimberly K. Vesco, M.D., M.P.H., from Kaiser Permanente Center for Health Research in Portland, Oregon, and colleagues evaluated the asso |
HealthDay
25 June at 03.04 PM
ADHD Meds May Help Control Opioid Use Disorder in PregnancyPsychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental Health.Kevin Y. Xu, M.D., M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues used U.S. multistate administrative data to examine the risks and benef |
HealthDay
25 June at 03.03 PM
Semaglutide Cuts Incidence, Recurrence of Alcohol Use DisorderSemaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according to a study published online May 28 in Nature Communications.William Wang, from Case Western Reserve University in Cleveland, and colleagues used electronic health records of 83,825 patients with obesity to examine associa |
HealthDay
25 June at 03.00 PM
SNP rs13194504 AA Genotype Linked to Severity of Tardive DyskinesiaFor patients with schizophrenia, the single-nucleotide polymorphism (SNP) rs13194504 AA genotype is associated with reduced severity of tardive dyskinesia (TD), but is not associated with occurrence, according to a study recently published in Human Psychopharmacology: Clinical & Experimental.Ruoyu Wang, from the Centre for Addictio |
HealthDay
25 June at 12.15 PM
Summer COVID Cases Are Rising Across AmericaAs scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday.In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states and aren’t declining anywhere in the c |
HealthDay
24 June at 09.25 PM
Medically Advised Aspirin Use Lower in 2021 Than 2012 to 2017Medically advised aspirin use was lower in 2021 than in 2012 to 2017 among older adults, according to a research letter published online June 25 in the Annals of Internal Medicine.Mohak Gupta, M.D., from the Cleveland Clinic, and colleagues characterized trends in prevalence of aspirin use for CVD prevention among U.S. adults aged 40 ye |
HealthDay
24 June at 09.20 PM
FDA Expands Approval for Duchenne Muscular Dystrophy Gene TherapyThe U.S. Food and Drug Administration has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in individuals ≥4 years with DMD with a confirmed mutation in the DMD gene.Elevidys is a single-dose, intravenous recombinant gene therapy designed to prod |
HealthDay
24 June at 03.23 PM
U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender YouthThe U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in that state.The banned treatments include puberty-blocking drugs or hormonal therapies.It's the |
HealthDay
24 June at 03.02 PM
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in MelanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random |
HealthDay
24 June at 11.44 AM
Twice-a-Year Injection Gives Women Full Protection Against HIV, Trial FindsJust two injections a year of a new HIV drug protected young women in Africa from infection with the sexually transmitted disease, new trial results show.In announcing the findings, Gilead Sciences Inc. said its HIV medication lenacapavir demonstrated 100% efficacy as a prev |
HealthDay
21 June at 10.54 PM
FDA Approves KEYTRUDA + Chemo for Primary Advanced, Recurrent Endometrial CarcinomaThe U.S. Food and Drug Administration has approved Keytruda (pembrolizumab) plus chemotherapy as treatment for adult patients with primary advanced or recurrent endometrial carcinoma. This is the third FDA-approved indication for Keytruda in endometrial carcinoma.The approval is for Keytruda, an anti-programmed death receptor-1 (anti-PD-1) |
HealthDay
21 June at 10.51 PM
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate VaccineThe U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.Capvaxive is specifically designed to help protect adults against the serotypes that cause the majority of invasive pneumococcal disease cases, inc |
HealthDay
21 June at 03.36 PM
Timing of Metformin Important in Metformin-Treated Type 2 DiabetesGlucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re |
HealthDay
21 June at 03.23 PM
Improved Outcomes Seen With Ibrutinib in Chronic Lymphocytic LeukemiaFirst-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic leukemia (CLL), according to a study published online May 13 in Clinical Lymphoma, Myeloma & Leukemia.Nilanjan Ghosh, M.D., Ph.D., from the Levine Cancer Institute in Charlotte, North Carolina, and colleagues condu |
HealthDay
21 June at 03.20 PM
Angiotensin Receptor Blocker Use Linked to Lower Incidence of EpilepsyFor patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other antihypertensive medications, according to a study published online June 17 in JAMA Neurology.Xuerong Wen, Ph.D., from the University of Rhode Island in Kingston, and colleagues conducted a retrosp |
HealthDay
21 June at 03.06 PM
Fewer Adults Eligible for Statins With PREVENT EquationsUse of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.Timothy S. Anderson, M.D., from the Univ |
HealthDay
21 June at 11.43 AM
WHO, Lilly Issue Warnings About Fake Weight-Loss DrugsBoth the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.The WHO warning said that the inter |
HealthDay
20 June at 08.47 PM
FDA Approves Augtyro for NTRK-Positive Advanced Solid TumorsThe U.S. Food and Drug Administration has approved Augtyro (repotrectinib), a next-generation tyrosine kinase inhibitor (TKI), for the treatment of patients with neurotrophic tyrosine receptor kinase (NTRK)-positive locally advanced or metastatic solid tumors.Augtyro is approved for adult and pediatric patients (aged 12 years and olde |
HealthDay
20 June at 04.00 PM
ViPOR Results in Durable Remission in Specific Subtypes of LymphomaFor patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) yields durable remission, according to a study published in the June 20 issue of the New England Journal of Medicine.Christopher Melani, M.D., fro |
HealthDay
20 June at 03.52 PM
About One-Third of Mental Health Facilities Offer Meds for Opioid AddictionAbout one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use disorder (MOUD), according to a study published online June 18 in JAMA Network Open.Jonathan Cantor, Ph.D., from RAND in Santa Monica, California, and colleagues quantified the availability of MOUD at community outpatien |
HealthDay
20 June at 03.34 PM
Reteplase Superior to Alteplase Within 4.5 Hours of Ischemic StrokeReteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to a study published online June 14 in the New England Journal of Medicine to coincide with the 10th Annual Conference of the Chinese Stroke Association & Tiantan International Stroke Conference 2024, held from June 14 |
HealthDay
19 June at 09.29 PM
Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor AntagonistsMen taking α-1 adrenergic receptor antagonists terazosin, doxazosin, and alfuzosin (Tz/Dz/Az) seem to have a lower risk for dementia with Lewy bodies (DLB), according to a study published online June 19 in Neurology.Alexander Hart, M.D., M.P.H., from the University of Michigan in Ann Arbor, and colleagues used a new-user active compa |
HealthDay
19 June at 03.55 PM
Low-Dose Direct Oral Anticoagulants Tied to More Bleeding EpisodesPatients with atrial fibrillation (AF) on low doses of direct oral anticoagulants (DOACs) have more bleeding episodes than those on standard doses, according to a study published online June 6 in Blood Advances.Gualtiero Palareti, M.D., from Fondazione Arianna Anticoagulazione in Bologna, Italy, and colleagues collected venous b |
HealthDay
19 June at 03.52 PM
Varenicline, Nicotine-Containing E-Cigarettes Help in Quitting SmokingVarenicline and nicotine-containing electronic cigarettes (ECs) are both effective in helping individuals in quitting smoking conventional cigarettes, according to a study published online June 17 in JAMA Internal Medicine.Anna Tuisku, Ph.D., from Lapland Central Hospital in Finland, and colleagues randomly assigned 458 particip |
HealthDay
19 June at 03.48 PM
Nearly One in Four Do Not Recover From COVID-19 by 90 DaysJust under one-quarter of adults with self-reported COVID-19 report they had not recovered by 90 days, according to a study published online June 17 in JAMA Network Open.Elizabeth C. Oelsner, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues used data from 14 ongoing National Institutes of |
HealthDay
18 June at 09.11 PM
Approximately 7 Percent of U.S. Population Uninsured in 2023In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from |
HealthDay
18 June at 03.49 PM
Trametinib Safe, Effective for Juvenile Myelomonocytic LeukemiaFor children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective, according to a study published online June 12 in Cancer Discovery.Noting that patients with relapsed or refractory (advanced) JMML have poor outcomes, Elliot Stieglitz, M.D., from the University of California San Francisc |
HealthDay
18 June at 03.46 PM
Multimodal Antiobesity Medications Yield Superior Preoperative Weight LossCombining antiobesity medications enhances preoperative weight loss in individuals with high body mass index (BMI) preparing for metabolic surgery, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.Michael Kachmar, D.O., from the Pennington Biome |
HealthDay
18 June at 03.44 PM
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment EffectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive |
HealthDay
18 June at 03.32 PM
Continuing Metformin in Pregnancy Has Little Effect on Nonlive BirthContinuing metformin and adding insulin in early pregnancy does not significantly alter the risk for nonlive birth or live birth with congenital malformations compared with switching to insulin monotherapy, according to a study published online June 18 in the Annals of Internal Medicine.Yu-Han Chiu, M.D., Sc.D., from the Harvard T.H. C |
HealthDay
18 June at 09.50 AM
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to ExpireIn a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h |
HealthDay
17 June at 10.55 PM
Paternal Metformin Use Not Linked to Major Congenital MalformationsPaternal use of metformin in monotherapy is not associated with an increased risk for major congenital malformations (MCMs), according to a study published online June 18 in the Annals of Internal Medicine.Ran S. Rotem, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the association between p |
HealthDay
17 June at 04.12 PM
2008 to 2021 Saw Increase in Prevalence of Chronic HTN in PregnancyFor pregnant individuals, the prevalence of chronic hypertension more than doubled between 2008 and 2021, according to a study published online June 17 in Hypertension.Stephanie A. Leonard, Ph.D., from the Stanford University School of Medicine in California, and colleagues analyzed commercial insurance claims from 2007 to 2021 and asse |
HealthDay
17 June at 04.09 PM
Few Receive Meds for Opioid Use Disorder After Nonfatal OverdoseIn the 12 months after a nonfatal overdose, few Medicare beneficiaries receive medications for opioid use disorder (MOUD) or fill a naloxone prescription, according to a study published online June 17 in JAMA Internal Medicine.Christopher M. Jones, Pharm.D., Dr.P.H., from the Substance Abuse and Mental Health Services Administration in |
HealthDay
17 June at 03.58 PM
Survodutide Tied to Significant Improvement in Fatty Liver DiseaseMost patients taking survodutide, a dual agonist of glucagon receptor and glucagon-like peptide-1 (GLP-1) receptor, experience significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) without worsening of fibrosis, according to a phase 2 study published online June 7 in the New England Journal of Medicine to |
HealthDay
17 June at 03.55 PM
Pantoprazole Cuts GI Bleeding in Patients Undergoing Invasive VentilationPantoprazole results in a significantly lower risk for clinically important upper gastrointestinal bleeding than placebo, with no increase in mortality, among patients undergoing invasive ventilation, according to a study published online June 14 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting, |
HealthDay
14 June at 08.51 PM
FDA Approves Generic Emflaza Oral Suspension for Duchenne Muscular DystrophyThe U.S. Food and Drug Administration has approved the first generic version of Emflaza (deflazacort) oral suspension for Duchenne muscular dystrophy (DMD).Deflazacort oral suspension is a corticosteroid indicated to treat DMD in patients 5 years of age and older but is contraindicated in patients with known hypersensitivity to deflazacort. The |
HealthDay
14 June at 03.35 PM
Prolonged β-Lactam Antibiotic Infusions Aid Sepsis, Septic Shock OutcomesAmong adults in the intensive care unit with sepsis or septic shock, the use of prolonged β-lactam antibiotic infusions is associated with lower risk of 90-day mortality compared with intermittent infusions, according to research published online June 12 in the Journal of the American Medical Association to coincide with the annual C |
HealthDay
14 June at 03.32 PM
No Evidence That Live Vaccines Are Unsafe for Patients on DupilumabThere is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma & Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub |
HealthDay
14 June at 12.05 PM
ADHD Patients Could Face Disrupted Access to Meds Following Fraud CaseThe two top officers of a telehealth company that began to distribute ADHD drugs widely during the pandemic have been charged with health care fraud, the U.S. Department of Justice announced Thursday.The arrests will likely worsen ongoing shortages of Adderall and another ADHD medication, Vyvanse, experts said.“There are a |
HealthDay
14 June at 10.50 AM
FDA Tells Vaccine Makers to Target New COVID Variant for FallCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday.It's a turnaround for the agency: The <a href="https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beg |
HealthDay
13 June at 10.58 PM
Health Care Spending Growth Projected to Outpace GDP to 2032Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected growth in national health expend |
HealthDay
13 June at 04.10 PM
GLP-1 RA Use Linked to Lower Quality of Bowel PreparationThe use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a study published online in the June issue of the American Journal of Gastroenterology.Rebecca Yao, M.D., M.P.H., from the Mayo Clinic in R |
HealthDay
13 June at 03.54 PM
Alternative Pembrolizumab Administration Yields Environmental AdvantagesAlternative pembrolizumab administration strategies may have environmental advantages, such as less carbon dioxide emission, according to a study published in the June issue of The Lancet Oncology.Alex K. Bryant, M.D., from the Veterans Affairs Center for Clinical Management Research in Ann Arbor, Michigan, and colleagues conducted a |
HealthDay
13 June at 03.46 PM
Tirzepatide Beneficial for Resolution of MASH in Patients With MASH, FibrosisFor patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-severe fibrosis, 52 weeks of tirzepatide is more effective than placebo for resolution of MASH, according to a study published online June 8 in the New England Journal of Medicine to coincide with the annual congress of the European Association for the |
HealthDay
13 June at 03.30 PM
Supreme Court Rejects Case That Would Have Curbed Access to Abortion DrugThe U.S. Supreme Court on Thursday threw out a case that aimed to curb access to the controversial abortion drug mifepristone, saying the plaintiffs who brought the case to the court had no legal standing to do so.In a unanimous vote, the nine judges <a href="https://www.supremecourt.gov/op |
HealthDay
13 June at 11.17 AM
J&J Settles Talcum Powder Lawsuits From States for $700 MillionJohnson & Johnson will pay $700 million to settle claims from 42 states and the District of Columbia that the company continued to market its talcum powder products even as evidence tied them to a heightened risk for cancer.J&J did not admit to any wrongdoing in settling with the states, which were led by Florida, Texas and North Carol |
HealthDay
12 June at 02.55 PM
Patients Can Take GLP-1 RA Medications Before SurgeryGlucagon-like peptide-1 receptor agonist (GLP-1 RA) medications do slow gastric emptying but not by enough to warrant discontinuing medications before surgery, according to a review published in the June issue of the American Journal of Gastroenterology.Brent Hiramoto, M.D., from Brigham and Women's Hospital in Boston, and colle |
HealthDay
12 June at 02.52 PM
ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm SuppressionA novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Danielle Gross, from the Eunice Kennedy Shriver National Institute of Child Health and Human Developme |
HealthDay
11 June at 03.58 PM
Systemic Side Effects of COVID-19 Vaccine Tied to Greater nAB ResponseShort-term systemic side effects of the severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA vaccine are associated with greater long-lasting neutralizing antibody (nAB) responses, according to a study published online June 11 in the Annals of Internal Medicine.Ethan G. Dutcher, M.D., Ph.D., from the University of California, San F |
HealthDay
11 June at 03.54 PM
Melatonin Use Linked to Reduced Risk for Development, Progression of AMDMelatonin use is associated with a reduced risk for development and progression of age-related macular degeneration (AMD), according to a study published online June 6 in JAMA Ophthalmology.Hejin Jeong, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a retrospective cohort study to exa |
HealthDay
11 June at 03.48 PM
No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD PatientsThere is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a history of cancer, according to a study published online May 18 in Clinical Gastroenterology and Hepatology.Steven H. Itzkowitz, M.D., from the Icahn School o |
HealthDay
11 June at 03.45 PM
ENDO: Teprotumumab Shows Long-Term Efficacy for Thyroid Eye DiseaseMost patients with thyroid eye disease treated with teprotumumab do not require additional treatments nearly two years later, according to a study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston, and simultaneously published online June 2 in Thyroid.George J. Kahaly, M.D., Ph.D., from the |
HealthDay
11 June at 12.58 PM
FDA Advisors Support New Alzheimer's DrugA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer's outweigh its harms, which can include brain swelling and bleeding.Eli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's: <a href="https://www.fda.gov/media/1791 |
HealthDay
10 June at 03.28 PM
Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAsBariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open.Dror Dicker, M.D., from Rabin Medical Center in Petah Tikva, |
HealthDay
10 June at 03.22 PM
Vitamin D Suggested for Children, Seniors, Those With High-Risk PrediabetesEmpiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk prediabetes, according to an Endocrine Society clinical practice guideline published online June 3 in the Journal of Clinical Endocrinology & Metabolism.Marie B. Demay, M.D., from M |
HealthDay
10 June at 03.10 PM
New Clinical Score Can Predict Immune Checkpoint Blockade ResponseFor patients with cancer, a novel clinical score using a six-feature regression model can predict immune checkpoint blockade (ICB) response probability and patient survival, according to a study published online June 3 in Nature Cancer.Tian-Gen Chang, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues an |
HealthDay
10 June at 03.07 PM
Nirmatrelvir-Ritonavir No Aid for Long COVID SymptomsA 15-day course of nirmatrelvir-ritonavir (NMV/r) is safe but does not demonstrate a significant benefit for improving postacute sequelae of SARS-CoV-2 infection (PASC) symptoms, according to a study published online June 7 in JAMA Internal Medicine to coincide with the Demystifying Long COVID North American Conference 2024, held from Jun |
HealthDay
10 June at 03.03 PM
Bulevirtide + Peginterferon Alfa-2a Best Treatment for Chronic Hepatitis DThe combination of bulevirtide plus peginterferon alfa-2a is superior to bulevirtide monotherapy for achieving undetectable hepatitis D virus (HDV) RNA level at 24 weeks after the end of treatment in patients with chronic hepatitis D, according to a study published online June 6 in the New England Journal of Medicine to coincide with the |
HealthDay
10 June at 01.02 PM
FDA Gives Nod to RSV Vaccine for People in Their 50sThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.Drugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved |
HealthDay
10 June at 12.22 PM
Moderna Announces Good Results From Trial of Combo COVID/Flu VaccineAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday.The shot — for now called mRNA-1083 — "has met its primary endpoints, eliciting a higher immune response than the licensed comparator vaccines used in the trial," Mo |
HealthDay
07 June at 03.34 PM
ASCO: Germline Variation Does Not Predict Taxane-Induced Peripheral NeuropathyGermline variation does not predict the risk of taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel (every three weeks) for early-stage breast cancer, according to a study published online June 3 in the Journal of Clinical Oncology to coincide with the annual meeting of the American Society |
HealthDay
07 June at 03.34 PM
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver DiseaseFor adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are associated with reduced risk of cardiovascular (CV) events compared with dipeptidyl peptidase 4 inhibitors (DPP-4i), according to a st |
HealthDay
07 June at 03.33 PM
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming TherapyIsotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen |
HealthDay
07 June at 03.32 PM
Mortality in Rheumatic Heart Disease Is HighMortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June 5 in the Journal of the American Medical Association.Ganesan Karthikeyan, D.M., from the All India Institute of Medical Sciences in New Delhi, and colleagues assessed the risk an |
HealthDay
06 June at 04.24 PM
Several Drugs Linked to Risk for Aneurysmal Subarachnoid HemorrhageSeveral commonly prescribed drugs are associated with aneurysmal subarachnoid hemorrhage (aSAH), according to a study published online June 5 in Neurology.Jos P. Kanning, from the University Medical Center Utrecht in the Netherlands, and colleagues conducted a drug-wide association study to examine the association between commonly pres |
HealthDay
06 June at 04.20 PM
Many Patients Have Discontinuation Symptoms After Stopping AntidepressantsA considerable proportion of patients have discontinuation symptoms (e.g., dizziness, headache, nausea, insomnia, and irritability) after discontinuing antidepressants, according to a review published online June 5 in The Lancet Psychiatry.Jonathan Henssler, M.D., from the University of Cologne in Germany, and colleagues conducted |
HealthDay
06 June at 04.12 PM
ASCO: Ivonescimab Improves Progression-Free Survival in EGFR+ Lung CancerFor patients with non-small cell lung cancer with the epidermal growth factor receptor (EGFR) variant, ivonescimab plus chemotherapy improves progression-free survival, according to a study published online May 31 in the Journal of the American Medical Association to coincide with the annual meeting of the American Society of Clinica |
HealthDay
06 June at 12.19 PM
FDA Panel OKs New COVID Vaccine for FallA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots.The unanimous vote recommends that vaccine makers tailor the next vaccine to target the JN.1 variant, which dominated infections in the Unite |
HealthDay
05 June at 09.18 PM
Neoadjuvant Nivolumab, Ipilimumab Safe for dMMR Colon CancerNeoadjuvant nivolumab plus ipilimumab has an acceptable safety profile in patients with locally advanced mismatch repair-deficient (dMMR) colon cancer, according to a study published in the June 6 issue of the New England Journal of Medicine.Myriam Chalabi, M.D., Ph.D., from the Netherlands Cancer Institute in Amsterdam, and colleague |
HealthDay
05 June at 09.15 PM
CDC Recommends Doxycycline PEP for Gay Men, Transgender WomenIn clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly Report, recommendations are presented for the use of doxycycline postexposure prophylaxis (doxy PEP) for preventing sexually transmitted infections (STIs) in gay, bisexual, and other men who |
HealthDay
05 June at 03.31 PM
ASCO: Osimertinib Improves Progression-Free Survival in EGFR-Mutated Lung CancerFor patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC), treatment with osimertinib results in significantly longer progression-free survival, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Clinical On |
HealthDay
05 June at 03.28 PM
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable MelanomaNeoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc |
HealthDay
05 June at 03.26 PM
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed LeukemiaFor patients with newly diagnosed chronic myeloid leukemia (CML), asciminib shows superior efficacy and a favorable safety profile compared with investigator-selected tyrosine kinase inhibitors (TKIs), according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual meeting of the American Socie |
HealthDay
05 June at 03.23 PM
ENDO: Crinecerfont Aids Patients With Congenital Adrenal HyperplasiaCrinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Richa |
HealthDay
05 June at 12.45 PM
FDA Panel Says No to MDMA as Treatment for PTSDA U.S. Food and Drug Administration advisory panel on Tuesday voted against recommending the psychedelic MDMA for the treatment of post-traumatic stress disorder (PTSD).In a 10-1 vote, the panel determined the evidence amassed so far fails to show the controversial drug's benefits outweigh its risks, the Associated Press reported. |
HealthDay
03 June at 09.00 PM
FDA Approves First Liquid, Nonstimulant ADHD TreatmentThe U.S. Food and Drug Administration has approved once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).The once-a-day, extended-release, oral suspension treatment is a centrally acting alpha2-adrenergic agonist. It has nighttime dosing for the treatment of A |
HealthDay
03 June at 03.59 PM
On-Demand Sebetralstat Speeds Symptom Relief in Hereditary AngioedemaFor patients with type 1 or type 2 hereditary angioedema, sebetralstat provides faster times to beginning of symptom relief than placebo, according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual congress of the European Academy of Allergy and Clinical Immunology, held from May 31 to June 3 |
HealthDay
03 June at 03.56 PM
Donidalorsen Cuts Attack Rate in Hereditary AngioedemaFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study published online May 31 in the New England Journal of Medicine to coincide with the annual congress of the European Academy of Allergy and Clinical Immunology, held from May 31 to June 3 in Valencia, Spain.Marc A. Riedl, M.D., from the Uni |
HealthDay
03 June at 03.53 PM
Plozasiran Reduces Triglyceride Levels in Mixed HyperlipidemiaFor individuals with mixed hyperlipidemia, plozasiran reduces triglyceride levels at 24 weeks, according to a study published online May 28 in the New England Journal of Medicine.Christie M. Ballantyne, M.D., from the Baylor College of Medicine and Texas Heart Institute in Houston, and colleagues conducted a 48-week, randomized trial ass |
HealthDay
03 June at 03.47 PM
No Decline in Cardiovascular Events Seen With COVID-19 Vaccine After Acute Coronary SyndromesPatients who have received at least one COVID-19 vaccine dose after acute coronary syndromes do not have a reduced risk for cardiovascular events, according to a research letter published online May 30 in JAMA Network Open.Henrique Andrade R. Fonseca, Ph.D., from Hospital Israelita Albert Einstein in São Paulo, Brazil, and colleagues con |
HealthDay
03 June at 12.25 PM
U.S. Will Make Millions of Bird Flu Vaccines This SummerAs the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans.Since the outbreak in livestock began this spring, bird flu has been confirmed in three humans who worked on dairy farms in Texas and Michigan, and health experts are concerned th |
HealthDay
31 May at 08.47 PM
Racial Disparity Seen in Naloxone AdministrationIn Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic people, according to a study published online May 29 in Addiction.Erin Takemoto, Ph.D., M.P.H., from the Pennsylvania Department of Health in Harrisburg, and colleagues characteriz |
HealthDay
31 May at 03.51 PM
Teens May Experience Delays in Bipolar Progression After Major Depressive DisorderAdolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis, according to a study published online May 29 in JAMA Psychiatry.Adrian E. Desai Boström, M.D., Ph.D., from the Karolinska Institute in Stockholm, and colleagues examined the association of age at MDD onset with early |
HealthDay
31 May at 03.43 PM
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DMFor patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from cardiovascular causes, according to a study published online May 24 in the New England Journal of Medicine to coincide with the annual European Renal Association Congress, held from May 23 to 26 in S |
HealthDay
30 May at 04.04 PM
Bimekizumab Yields Meaningful Response in Hidradenitis SuppurativaBimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b |
HealthDay
30 May at 03.55 PM
Inappropriate Antibiotic Prescribing Identified in Safety-Net PopulationsInappropriate antibiotic prescribing is common with or without a plausible antibiotic indication, and inappropriate prescribing is also common in U.S. emergency department visits, according to a study published online April 26 in the Journal of General Internal Medicine and a second study published May 14 in Antimicrobial Stewardship and |
HealthDay
30 May at 03.42 PM
Some Healthy Teens Are Given Cannabidiol for Health ReasonsAbout 3 percent of healthy adolescents are given commercial cannabidiol (CBD) for health reasons, according to a study published online May 7 in Cannabis and Cannabinoid Research.Natasha E. Wade, Ph.D., from the University of California in San Diego, and colleagues described the characteristics of adolescents given health-related CBD ( |
HealthDay
29 May at 09.19 PM
In Utero Exposure to Antiseizure Meds Does Not Affect Child CreativityThere are no differences in creative thinking at age 4.5 years for children of women with epilepsy (WWE) and children of healthy women (HW), but fetal antiseizure medication (ASM) exposure-dependent effects are seen for executive function in children of WWE, according to a study published online May 29 in Neurology.Kimford J. Meador, |
HealthDay
29 May at 09.17 PM
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care SpendingFrom 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro |
HealthDay
29 May at 09.16 PM
Pharmacological Treatment of ADHD May Cut Some Forms of CriminalityPharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD), according to a study published online in the April issue of the Journal of the American Academy of Child and Adolescent Psychiatry.Tarjei Widding-Havneraas, from Haukeland University H |
HealthDay
29 May at 03.06 PM
Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist DiscontinuationSpecific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.Duy Do, Ph.D., from the Evernorth Research Institute in St. Louis, and colleagues estimated the prevalence |
HealthDay
29 May at 03.05 PM
Chemo + Breast Cancer Combo Accelerates Functional Decline in SeniorsThe combination of breast cancer and chemotherapy contributes to accelerated functional decline in older women with early-stage breast cancer, according to a study published online April 28 in the Journal of Cancer Survivorship.Mina S. Sedrak, M.D., from the University of California Los Angeles David Geffen School of Medicine, an |
HealthDay
28 May at 10.06 PM
Infarct Size Does Not Affect Treatment Effect of Early Versus Late DOACFor individuals with minor, moderate, or major stroke, the treatment effect of early versus late direct oral anticoagulant (DOAC) initiation does not differ, according to a study published online May 28 in JAMA Neurology.Martina B. Goeldlin, M.D., Ph.D., from the University of Bern in Switzerland, and colleagues examined whether infarct |
HealthDay
28 May at 03.49 PM
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular DiseaseOnce-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study presented at the annual European Renal Association Congress, held from May 23 to 26 in Stockholm.Helen M. Colhoun, M.D., from the University of Edinburgh in the United Kingdom, |
HealthDay
28 May at 03.22 PM
Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and OlderFor patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published online May 28 in the Annals of Internal Medicine.Wanchun Xu, M.Phil., from the University of Hong Kong, and colleagues examined the benefits and risks of using statins for primary pre |
HealthDay
28 May at 02.56 PM
ASCO: Conjugated Equine Estrogen May Increase Risk for Ovarian CancerConjugated equine estrogen (CEE) taken alone for menopause may increase the risk for developing and dying from ovarian cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.Rowan T. Chlebowski, M.D., Ph.D., from the Lundquist Institute in Torrance, Califor |
HealthDay
24 May at 04.06 PM
Antihypertensives Linked to Eczematous Dermatitis in SeniorsAntihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine |
HealthDay
24 May at 04.01 PM
Donepezil Not Beneficial for Cognitive Impairment in Breast Cancer SurvivorsA once-daily dose of donepezil does not improve cognitive function among breast cancer survivors exposed to chemotherapy one to five years earlier, according to a study published online May 6 in the Journal of Clinical Oncology.Stephen R. Rapp, Ph.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, an |
HealthDay
24 May at 11.21 AM
Louisiana Votes to Make Abortion Pills Controlled SubstancesLouisiana has become the first state to pass a law that designates abortion pills as dangerous controlled substances.Once Gov. Jeff Landry signs the bill into law, as he is expected to do, possession of the drugs mifepristone and <a href="https://www.dr |
HealthDay
23 May at 09.18 PM
ASCO: HPV Vaccination Positively Affecting More Than Just Cervical Cancer RiskHuman papillomavirus (HPV) vaccination is associated with reduced odds of several types of HPV-related cancers, not just cervical cancer, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.Jefferson DeKloe, from Thomas Jefferson University in Philadelphia, and |
HealthDay
23 May at 04.06 PM
Few Adults With Moderate, Severe Asthma Receive Recommended Inhaler RegimenOnly 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) inhaler regimen, according to a study presented at the American Thoracic Society 2024 International Conference, held from May 17 to 22 in San Diego.Zoe Zimmerman, from the Yale School of Medicine in N |
HealthDay
23 May at 03.55 PM
Metformin Use Linked to Lower Odds of Myeloproliferative NeoplasmsMetformin use, including long-term use, is associated with significantly lower odds of myeloproliferative neoplasm (MPN) diagnosis, according to a study published online May 17 in Blood Advances.Daniel Tuyet Kristensen, M.D., from Aalborg University Hospital in Denmark, and colleagues conducted a population-based case-control study usi |
HealthDay
23 May at 03.44 PM
Rates of Severe Multiple Drug Intolerance Syndrome Up in Fibromyalgia, IBSPatients with fibromyalgia and irritable bowel syndrome (IBS) have increased rates of severe multiple drug intolerance syndrome (MDIS), according to a study published in the May issue of the Journal of Allergy and Clinical Immunology: In Practice.Alicia A. Alvarez, M.D., from Sarasota Memorial Hospital in Florida, and colleagues conduc |
HealthDay
22 May at 09.01 PM
FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus ErythematosusThe U.S. Food and Drug Administration has approved a 200-mg subcutaneous route of administration of Benlysta (belimumab) for patients 5 years of age and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy.The B-lymphocyte stimulator-specific inhibiting monoclonal antibody was previously approved for children |
HealthDay
22 May at 04.11 PM
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young AdultsFor adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research letter published online May 22 in the Journal of the American Medical Association.Joyce M. Lee, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues |
HealthDay
22 May at 04.09 PM
Fish Oil Beneficial for Reducing Risk for Cardiovascular Disease ProgressionThe role of regular use of fish oil supplements varies for people with and without cardiovascular disease, according to a study published online May 21 in BMJ Medicine.Ge Chen, Dr.P.H., from Sun Yat-Sen University in Guangzhou, China, and colleagues conducted a prospective cohort study to examine the effects of fish oil supplements on |
HealthDay
21 May at 03.14 PM
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 InflammationDupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a study published online May 20 in the New England Journal of Medicine to coincide with the American Thoracic Society 2024 International Conference, held from May 17 to 22 in San Diego.Su |
HealthDay
21 May at 03.03 PM
Neurobehavioral Issues Increased in Children With Prenatal Fluoride ExposurePrenatal fluoride exposure is associated with increased neurobehavioral problems, according to a study published online May 20 in JAMA Network Open.Ashley J. Malin, Ph.D., from the University of Florida in Gainesville, and colleagues examined associations of third-trimester maternal urinary fluoride (MUF) with child neurobehavior at age |
HealthDay
20 May at 10.32 PM
Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot FlashesFezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by the European Society of Endocrinology from May 11 to 14 in Stockholm.Angelica Lindén Hirschberg, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleague |
HealthDay
20 May at 03.55 PM
Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD PatientsFor patients with chronic obstructive pulmonary disease (COPD), bisoprolol does not reduce the number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both, according to a study published online May 19 in the Journal of the American Medical Association to coincide with the American Thoracic Society 2024 Internat |
HealthDay
20 May at 03.47 PM
Guideline Developed for Glucocorticoid-Induced Adrenal InsufficiencyIn a clinical guideline issued jointly by the European Society of Endocrinology and the Endocrine Society, recommendations are presented for the diagnosis and management of glucocorticoid-induced adrenal insufficiency. The guideline was published online May 8 simultaneously in the European Journal of Endocrinology and the Journal of Clinica |
HealthDay
20 May at 03.41 PM
Acetaminophen Does Not Improve Survival in Adults With SepsisFor adults with sepsis, intravenous acetaminophen is safe but does not significantly improve the number of days alive and free of organ support, according to a study published online May 19 in the Journal of the American Medical Association to coincide with the American Thoracic Society 2024 International Conference, held from May 17 to 22 in S |
HealthDay
17 May at 04.30 PM
Andexanet Yields Better Control of Hematoma Expansion Than Usual CareFor patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects of factor Xa inhibitors, results in better control of hematoma expansion than usual care, according to a study published in the May 16/23 issue of the New England Journal of Medicine. |
HealthDay
17 May at 04.18 PM
Perioperative Nivolumab Tops Chemo for Survival in Resectable Lung CancerFor patients with resectable non-small cell lung cancer (NSCLC), perioperative treatment with nivolumab results in significantly longer event-free survival, according to a study published in the May 16/23 issue of the New England Journal of Medicine.Tina Cascone, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Hous |
HealthDay
17 May at 04.00 PM
AAN Issues Guideline for Use of Antiseizure Meds in People of Childbearing PotentialIn a practice guideline issued by the American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine, recommendations are presented for the use of antiseizure medications (ASMs) among people with epilepsy of childbearing potential (PWECP). The guideline was published online May 15 in Neurology</em |
HealthDay
17 May at 12.03 PM
FDA Approves New Drug for Deadly Lung CancerThe U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for pa |
HealthDay
16 May at 09.18 PM
Semaglutide Reduces Need for Diuretics in Heart FailureSemaglutide reduces the need for loop diuretics and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF), regardless of diuretic use, according to a study presented at the European Society of Cardiology Heart Failure 2024, held from May 11 to 14 in Lisbon, Portu |
HealthDay
16 May at 04.06 PM
Aficamten Beneficial for Obstructive Hypertrophic CardiomyopathyTreatment with the oral selective cardiac myosin inhibitor aficamten results in significantly greater improvement in peak oxygen uptake compared with placebo among patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), according to a study published online May 13 in the New England Journal of Medicine to coincide with the Eu |
HealthDay
16 May at 03.57 PM
Quality Improvement Initiative Boosts Early HPV Vaccine RatesA multipronged primary care quality improvement initiative increases early human papillomavirus (HPV) vaccine initiation across racial/ethnic, sociodemographic, insurance, and geographic groups, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from May 2 to 6 in Toronto.Caitlin Miller, from Nemours |
HealthDay
16 May at 03.32 PM
Oldest Adults With Acute Myeloid Leukemia Benefit From VenetoclaxFor older adults with acute myeloid leukemia (AML), venetoclax (VEN) combined with a hypomethylating agent (HMA) is safe and effective and can prolong survival, according to a study published online May 7 in Blood Neoplasia.Ellen Madarang, Pharm.D., from the University of Miami Sylvester Comprehensive Cancer Center, and colleagues cond |
HealthDay
15 May at 03.45 PM
AACR Delivers Report on Disparities in Cancer ProgressIn its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un |
HealthDay
15 May at 03.23 PM
GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant PrescriptionIndividuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in Diabetes, Obesity, and Metabolism.Osvaldo P. Almeida, Ph.D., from University of Notre Dame in Fremantle, Australia, and colleagues assessed whet |
HealthDay
14 May at 10.41 PM
Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor AgonistOne in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released May 10.Alex Montero, from KFF Health, and colleagues analyzed data collected April 23 to May 1, 2024, online and by te |
HealthDay
14 May at 05.05 PM
About 8,000 Women Per Month Are Getting Abortion Pills Despite Their States' BansWhile some states have moved to severely curb women's access to abortion, including abortion pills, over 8,000 women living in those states are getting the pills by mail each month from states without such restrictions.That's according to new data from a <a href="https://societyfp.org/wp-content/uploads/2024/05/WeCount-report-6-May-2024-Dec-2023 |
HealthDay
14 May at 03.44 PM
Risk From Regular Cannabis Use Perceived as Low in Women With DisabilitiesWomen with disabilities have a low likelihood of perceiving a risk for harm from weekly cannabis use, according to a study recently published online in Cannabis and Cannabinoid Research.Panagiota Kitsantas, Ph.D., from Florida Atlantic University in Boca Raton, and colleagues examined the perceived risk for harm from weekly cannabi |
HealthDay
13 May at 03.57 PM
Mail-Order Mifepristone Effective, Feasible for Medication AbortionMail-order pharmacy dispensing of mifepristone for medication abortion is effective, acceptable, and feasible, according to a study published online May 13 in JAMA Internal Medicine.Daniel Grossman, M.D., from the University of California, San Francisco, and colleagues estimated the effectiveness, acceptability, and feasibility of dispen |
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Medpage Today
25 October at 02.09 PM
Patients More Satisfied With AI's Answers Than Those From Their DoctorPatients were consistently more satisfied with responses from artificial intelligence (AI) to messages in the electronic health record than they were with those from their clinician, according to a study in JAMA Network Open... |
Medical xPress
25 October at 12.40 PM
Surgical innovation: The intelligent turbine insufflatorThe Politecnico di Milano and the Erasmus Medical Center in Rotterdam have pooled their medical and technical expertise to create a new technology for devices called "insufflators." These innovative instruments are designed to create a temporary cavity in the bodies of patients through the application of pressurized gas, providing the surgeon with the necessary space to perform the surgical proced |
Medical xPress
24 October at 07.50 AM
Genetic variants in melatonin receptor linked to idiopathic osteoporosisColumbia University Medical Center researchers have identified specific variants in a melatonin receptor gene that impair bone turnover, leading to significant reductions in bone density and increased risk of fractures, particularly in Ashkenazi Jewish individuals. |
HealthDay
23 October at 10.58 PM
Risk for Psychiatric Disorders Up for Offspring of Moms With Eating DisorderOffspring of mothers with an eating disorder or prepregnancy body mass index (BMI) outside the normal weight range have an increased risk for psychiatric disorders, according to a study published online Oct. 22 in JAMA Network Open.Ida A.K. Nilsson, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a popula |